| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | enzyme-substrate adaptor activity | PRAMEF9 RRAGC PIK3R1 PRAMEF26 PRAMEF11 PRAMEF15 PRAMEF4 KBTBD2 PRAMEF27 | 1.81e-06 | 95 | 235 | 9 | GO:0140767 |
| GeneOntologyMolecularFunction | helicase activity | ATRX TDRD9 DHX9 HELZ DHX16 CHD5 SMARCA2 SMARCA4 POLQ SNRNP200 | 1.84e-05 | 158 | 235 | 10 | GO:0004386 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | TRPM6 ATR HIPK1 STK32B CSNK1A1L CSNK1G1 ROCK2 GRK1 PIKFYVE LIMK2 CSNK1A1 CSNK1D CSNK1E CSNK1G2 CSNK1G3 PRKAB2 NLK | 2.32e-05 | 446 | 235 | 17 | GO:0004674 |
| GeneOntologyMolecularFunction | protein serine kinase activity | TRPM6 ATR HIPK1 STK32B CSNK1A1L CSNK1G1 ROCK2 PIKFYVE LIMK2 CSNK1A1 CSNK1D CSNK1E CSNK1G2 CSNK1G3 NLK | 2.82e-05 | 363 | 235 | 15 | GO:0106310 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA2 ATRX CCT3 TDRD9 MYO6 VWA8 DNAH14 DHX9 HELZ DHX16 SMC2 DNAH7 DNAH12 CHD5 SMARCA2 SMARCA4 MYH15 POLQ SNRNP200 TP53 | 4.19e-05 | 614 | 235 | 20 | GO:0140657 |
| GeneOntologyMolecularFunction | ubiquitin-like ligase-substrate adaptor activity | 5.14e-05 | 82 | 235 | 7 | GO:1990756 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 6.94e-05 | 37 | 235 | 5 | GO:0042923 | |
| GeneOntologyMolecularFunction | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity | 1.38e-04 | 2 | 235 | 2 | GO:0004572 | |
| GeneOntologyMolecularFunction | protein kinase activity | TRPM6 ATR HIPK1 STK32B CSNK1A1L CSNK1G1 ROCK2 GRK1 PIKFYVE LIMK2 RNASEL CSNK1A1 CSNK1D CSNK1E CSNK1G2 CSNK1G3 PRKAB2 NLK | 2.81e-04 | 600 | 235 | 18 | GO:0004672 |
| GeneOntologyMolecularFunction | peptide binding | TPP2 MAS1 MC3R MC4R CSNK1A1L KPNA5 NPY5R RANBP6 GSS OPRL1 CSNK1A1 SORL1 | 4.09e-04 | 318 | 235 | 12 | GO:0042277 |
| GeneOntologyMolecularFunction | tachykinin receptor activity | 4.11e-04 | 3 | 235 | 2 | GO:0004995 | |
| GeneOntologyMolecularFunction | melanocyte-stimulating hormone receptor activity | 4.11e-04 | 3 | 235 | 2 | GO:0004980 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 4.66e-04 | 55 | 235 | 5 | GO:0042974 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | TRPM6 ATR HIPK1 STK32B CSNK1A1L PIK3R1 CSNK1G1 ROCK2 GRK1 PIKFYVE LIMK2 RNASEL CSNK1A1 CSNK1D CSNK1E CSNK1G2 CSNK1G3 PRKAB2 NLK | 7.61e-04 | 709 | 235 | 19 | GO:0016773 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA2 ATRX CCT3 TDRD9 VWA8 DHX9 DHX16 SMC2 DNAH7 DNAH12 CHD5 SMARCA4 POLQ SNRNP200 | 7.75e-04 | 441 | 235 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | small conductance calcium-activated potassium channel activity | 8.15e-04 | 4 | 235 | 2 | GO:0016286 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 9.10e-04 | 37 | 235 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 9.10e-04 | 37 | 235 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 1.01e-03 | 133 | 235 | 7 | GO:0008528 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.15e-03 | 18 | 235 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | dolichyl-diphosphooligosaccharide-protein glycotransferase activity | 1.35e-03 | 5 | 235 | 2 | GO:0004579 | |
| GeneOntologyMolecularFunction | oligosaccharyl transferase activity | 1.35e-03 | 5 | 235 | 2 | GO:0004576 | |
| GeneOntologyMolecularFunction | histone H3K27me2/H3K27me3 demethylase activity | 1.35e-03 | 5 | 235 | 2 | GO:0071558 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 1.37e-03 | 140 | 235 | 7 | GO:0001653 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | PIK3R1 PRAMEF26 PRAMEF11 PRAMEF15 PRAMEF4 JMJD1C SMARCA4 PRAMEF27 | 1.72e-03 | 187 | 235 | 8 | GO:0016922 |
| GeneOntologyMolecularFunction | kinase activity | TRPM6 ATR HIPK1 STK32B CSNK1A1L PIK3R1 CSNK1G1 ROCK2 GRK1 PIKFYVE LIMK2 RNASEL CSNK1A1 CSNK1D CSNK1E CSNK1G2 CSNK1G3 PRKAB2 NLK | 1.81e-03 | 764 | 235 | 19 | GO:0016301 |
| GeneOntologyMolecularFunction | chromo shadow domain binding | 2.01e-03 | 6 | 235 | 2 | GO:0070087 | |
| GeneOntologyMolecularFunction | melanocortin receptor activity | 2.01e-03 | 6 | 235 | 2 | GO:0004977 | |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | CAB39 ATR HIPK1 STK32B CSNK1A1L CSNK1G1 ROCK2 PIKFYVE CSNK1A1 CSNK1D CSNK1E CSNK1G2 CSNK1G3 TENM1 NLK | 2.36e-06 | 307 | 233 | 15 | GO:0018105 |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | CAB39 ATR HIPK1 STK32B CSNK1A1L CSNK1G1 ROCK2 PIKFYVE CSNK1A1 CSNK1D CSNK1E CSNK1G2 CSNK1G3 TENM1 NLK | 3.76e-06 | 319 | 233 | 15 | GO:0018209 |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | ATR ATRX CCT3 HDAC8 NCAPD2 ANAPC5 ANAPC4 SMC2 TERF1 SMARCA2 SMARCA4 PCID2 TP53 | 1.12e-05 | 266 | 233 | 13 | GO:0033044 |
| GeneOntologyBiologicalProcess | amyloid-beta metabolic process | 1.28e-05 | 69 | 233 | 7 | GO:0050435 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | ATR ATRX CCT3 CARD10 MDM2 RRAGC DHX9 PYHIN1 FSIP2 MGAT3 PIK3R1 CPLANE1 NIPBL KPNA5 ROCK2 SGTB NUP107 FERMT1 RANBP6 TERF1 PIKFYVE LIMK2 VPS13D CSNK1D PES1 TP53 HTT SORL1 | 4.42e-05 | 1091 | 233 | 28 | GO:0033365 |
| GeneOntologyBiologicalProcess | regulation of amyloid precursor protein catabolic process | 5.32e-05 | 59 | 233 | 6 | GO:1902991 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | ABCA2 ATR LRFN3 BIN3 CYFIP1 CSNK1A1L PTPRD NRXN2 SACS PIK3R1 ARHGEF9 TACR1 ROCK2 TAPT1 VPS39 FERMT1 DOCK10 TERF1 HAUS2 CYFIP2 PIKFYVE LIMK2 CSNK1A1 TENM1 ARHGAP28 UNC13A TP53 HTT SORL1 | 7.92e-05 | 1189 | 233 | 29 | GO:0044087 |
| GeneOntologyBiologicalProcess | positive regulation of amyloid-beta formation | 1.19e-04 | 23 | 233 | 4 | GO:1902004 | |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | TTLL5 DNAH14 FSIP2 PGAM4 TACR1 TACR3 CFAP70 DNAH7 DNAH12 CFAP46 | 1.44e-04 | 210 | 233 | 10 | GO:0060294 |
| GeneOntologyBiologicalProcess | regulation of protein localization to early endosome | 1.61e-04 | 10 | 233 | 3 | GO:1902965 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to early endosome | 1.61e-04 | 10 | 233 | 3 | GO:1902966 | |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | TTLL5 DNAH14 FSIP2 PGAM4 TACR1 TACR3 CFAP70 DNAH7 DNAH12 CFAP46 | 1.75e-04 | 215 | 233 | 10 | GO:0060285 |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | TTLL5 DNAH14 FSIP2 PGAM4 TACR1 TACR3 CFAP70 DNAH7 DNAH12 CFAP46 | 1.75e-04 | 215 | 233 | 10 | GO:0001539 |
| GeneOntologyBiologicalProcess | amyloid precursor protein catabolic process | 1.76e-04 | 73 | 233 | 6 | GO:0042987 | |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | 1.38e-05 | 47 | 235 | 6 | GO:0031462 | |
| GeneOntologyCellularComponent | microtubule organizing center | CEP104 ABCA2 DIS3L HIPK1 TTLL5 TTC19 DHX9 CSNK1A1L ASPM CFAP70 PPP2R3C ROCK2 TAPT1 HAUS2 KIFAP3 LIMK2 CCDC42 WDR11 CSNK1A1 CSNK1D CCNB2 RTRAF SKA3 CCDC102B TP53 HTT | 1.53e-05 | 919 | 235 | 26 | GO:0005815 |
| GeneOntologyCellularComponent | cilium | CEP104 TTLL5 PTCH1 DNAH14 FSIP2 CSNK1A1L PGAM4 TACR1 TACR3 CFAP70 CPLANE1 PRAMEF11 RPGRIP1 TAPT1 PRAMEF15 PRAMEF4 DNAH7 GRK1 KIFAP3 DNAH12 CCDC42 WDR11 CSNK1A1 CSNK1D CFAP46 | 2.94e-05 | 898 | 235 | 25 | GO:0005929 |
| GeneOntologyCellularComponent | centrosome | CEP104 DIS3L HIPK1 TTLL5 TTC19 DHX9 CSNK1A1L ASPM PPP2R3C ROCK2 TAPT1 HAUS2 KIFAP3 LIMK2 CCDC42 CSNK1A1 CSNK1D CCNB2 RTRAF SKA3 TP53 | 1.74e-04 | 770 | 235 | 21 | GO:0005813 |
| MousePheno | abnormal male germ cell physiology | TDRD9 ASPM FAR1 PRAMEF26 PRAMEF11 PICK1 CUL4A PRAMEF15 PRAMEF4 JMJD1C LIMK2 FANCI PRAMEF27 TP53 | 5.14e-06 | 244 | 187 | 14 | MP:0020362 |
| MousePheno | increased male germ cell apoptosis | TDRD9 FAR1 PRAMEF26 PRAMEF11 PICK1 CUL4A PRAMEF15 PRAMEF4 JMJD1C LIMK2 FANCI PRAMEF27 | 8.93e-06 | 189 | 187 | 12 | MP:0014052 |
| MousePheno | decreased testis weight | ATR TDRD9 ASPM TAF4B FAR1 PRAMEF26 PRAMEF11 PICK1 CUL4A PRAMEF15 PRAMEF4 JMJD1C LIMK2 CSNK1G2 FANCI PRAMEF27 TP53 | 9.82e-06 | 370 | 187 | 17 | MP:0004852 |
| MousePheno | abnormal germ cell physiology | TDRD9 ASPM FAR1 PRAMEF26 PRAMEF11 PICK1 CUL4A PRAMEF15 PRAMEF4 JMJD1C LIMK2 FANCI PRAMEF27 TP53 | 1.43e-05 | 267 | 187 | 14 | MP:0020363 |
| MousePheno | abnormal male germ cell apoptosis | TDRD9 FAR1 PRAMEF26 PRAMEF11 PICK1 CUL4A PRAMEF15 PRAMEF4 JMJD1C LIMK2 FANCI PRAMEF27 TP53 | 1.74e-05 | 236 | 187 | 13 | MP:0008280 |
| MousePheno | abnormal testis weight | ATR TDRD9 ASPM TAF4B FAR1 PRAMEF26 PRAMEF11 PICK1 CUL4A PRAMEF15 PRAMEF4 JMJD1C LIMK2 CSNK1G2 FANCI PRAMEF27 TP53 | 2.00e-05 | 391 | 187 | 17 | MP:0004850 |
| MousePheno | abnormal spermatogonia proliferation | 3.60e-05 | 47 | 187 | 6 | MP:0002685 | |
| MousePheno | retina spots | 1.03e-04 | 19 | 187 | 4 | MP:0012671 | |
| MousePheno | decreased germ cell number | MAN2A2 ATR TDRD9 ADGRG1 FSIP2 AP1G1 ASPM CFAP70 TAF4B FAR1 PRAMEF26 PRAMEF11 PICK1 CUL4A PRAMEF15 PRAMEF4 JMJD1C RFWD3 CCDC42 FANCI CHD5 PRAMEF27 | 1.30e-04 | 687 | 187 | 22 | MP:0002209 |
| MousePheno | decreased male germ cell number | MAN2A2 TDRD9 ADGRG1 FSIP2 AP1G1 ASPM CFAP70 TAF4B FAR1 PRAMEF26 PRAMEF11 PICK1 CUL4A PRAMEF15 PRAMEF4 JMJD1C RFWD3 CCDC42 FANCI CHD5 PRAMEF27 | 1.33e-04 | 640 | 187 | 21 | MP:0004901 |
| Domain | ARM-type_fold | CEP104 CAB39 ATR NBEAL1 LYST CLHC1 URB1 AP1G1 NCAPD2 ASPM CAB39L NIPBL KPNA5 RANBP6 KIFAP3 ELMO2 HTT | 1.17e-06 | 339 | 231 | 17 | IPR016024 |
| Domain | CK1gamma_C | 1.87e-06 | 3 | 231 | 3 | PF12605 | |
| Domain | Casein_kinase-1_gamma_C | 1.87e-06 | 3 | 231 | 3 | IPR022247 | |
| Domain | - | CEP104 CAB39 ATR AP1G1 NCAPD2 ASPM CAB39L NIPBL KPNA5 RANBP6 KIFAP3 ELMO2 HTT | 4.14e-06 | 222 | 231 | 13 | 1.25.10.10 |
| Domain | ARM-like | CEP104 CAB39 ATR AP1G1 NCAPD2 ASPM CAB39L NIPBL KPNA5 DOCK10 RANBP6 KIFAP3 ELMO2 HTT | 7.20e-06 | 270 | 231 | 14 | IPR011989 |
| Domain | Helicase_C | 7.26e-06 | 107 | 231 | 9 | PF00271 | |
| Domain | HELICc | 7.26e-06 | 107 | 231 | 9 | SM00490 | |
| Domain | Tox-GHH_dom | 7.40e-06 | 4 | 231 | 3 | IPR028916 | |
| Domain | Pecanex_C | 7.40e-06 | 4 | 231 | 3 | PF05041 | |
| Domain | Tox-GHH | 7.40e-06 | 4 | 231 | 3 | PF15636 | |
| Domain | Ten_N | 7.40e-06 | 4 | 231 | 3 | IPR009471 | |
| Domain | Ten_N | 7.40e-06 | 4 | 231 | 3 | PF06484 | |
| Domain | TENEURIN_N | 7.40e-06 | 4 | 231 | 3 | PS51361 | |
| Domain | Pecanex | 7.40e-06 | 4 | 231 | 3 | IPR007735 | |
| Domain | Helicase_C | 7.84e-06 | 108 | 231 | 9 | IPR001650 | |
| Domain | HELICASE_CTER | 8.45e-06 | 109 | 231 | 9 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 8.45e-06 | 109 | 231 | 9 | PS51192 | |
| Domain | DEXDc | 8.45e-06 | 109 | 231 | 9 | SM00487 | |
| Domain | Helicase_ATP-bd | 9.11e-06 | 110 | 231 | 9 | IPR014001 | |
| Domain | YD | 1.83e-05 | 5 | 231 | 3 | IPR006530 | |
| Domain | PRAME_family | 7.64e-05 | 19 | 231 | 4 | IPR026271 | |
| Domain | HEAT | 7.93e-05 | 58 | 231 | 6 | IPR000357 | |
| Domain | Cytoplasmic_FMR1-int | 1.52e-04 | 2 | 231 | 2 | IPR008081 | |
| Domain | Mo25 | 1.52e-04 | 2 | 231 | 2 | IPR013878 | |
| Domain | Gln-Leu-Gln_QLQ | 1.52e-04 | 2 | 231 | 2 | IPR014978 | |
| Domain | Mo25 | 1.52e-04 | 2 | 231 | 2 | PF08569 | |
| Domain | SnAC | 1.52e-04 | 2 | 231 | 2 | PF14619 | |
| Domain | QLQ | 1.52e-04 | 2 | 231 | 2 | SM00951 | |
| Domain | QLQ | 1.52e-04 | 2 | 231 | 2 | PS51666 | |
| Domain | SnAC | 1.52e-04 | 2 | 231 | 2 | SM01314 | |
| Domain | SnAC | 1.52e-04 | 2 | 231 | 2 | IPR029295 | |
| Domain | FragX_IP | 1.52e-04 | 2 | 231 | 2 | PF05994 | |
| Domain | UPF0028 | 1.52e-04 | 2 | 231 | 2 | PS01237 | |
| Domain | QLQ | 1.52e-04 | 2 | 231 | 2 | PF08880 | |
| Domain | - | 2.64e-04 | 207 | 231 | 10 | 1.25.40.10 | |
| Domain | Pkinase | HIPK1 STK32B CSNK1A1L CSNK1G1 ROCK2 GRK1 LIMK2 RNASEL CSNK1A1 CSNK1D CSNK1E CSNK1G2 CSNK1G3 NLK | 2.96e-04 | 381 | 231 | 14 | PF00069 |
| Domain | HEAT | 3.08e-04 | 48 | 231 | 5 | PF02985 | |
| Domain | Rhs_assc_core | 4.53e-04 | 3 | 231 | 2 | IPR022385 | |
| Domain | Neurokn_rcpt | 4.53e-04 | 3 | 231 | 2 | IPR001681 | |
| Domain | Melancort_rcpt | 4.53e-04 | 3 | 231 | 2 | IPR001908 | |
| Domain | Unc-13 | 4.53e-04 | 3 | 231 | 2 | IPR027080 | |
| Domain | NHL | 4.87e-04 | 13 | 231 | 3 | PS51125 | |
| Domain | Ser/Thr_kinase_AS | HIPK1 STK32B CSNK1A1L CSNK1G1 ROCK2 GRK1 LIMK2 CSNK1A1 CSNK1D CSNK1E CSNK1G2 CSNK1G3 NLK | 5.28e-04 | 357 | 231 | 13 | IPR008271 |
| Domain | PROTEIN_KINASE_ST | HIPK1 STK32B CSNK1A1L CSNK1G1 ROCK2 GRK1 LIMK2 CSNK1A1 CSNK1D CSNK1E CSNK1G2 CSNK1G3 NLK | 6.01e-04 | 362 | 231 | 13 | PS00108 |
| Domain | Dynein_heavy_chain_D4_dom | 6.15e-04 | 14 | 231 | 3 | IPR024317 | |
| Domain | AAA_8 | 6.15e-04 | 14 | 231 | 3 | PF12780 | |
| Domain | SNF2_N | 6.25e-04 | 32 | 231 | 4 | IPR000330 | |
| Domain | SNF2_N | 6.25e-04 | 32 | 231 | 4 | PF00176 | |
| Domain | TPR-like_helical_dom | 6.69e-04 | 233 | 231 | 10 | IPR011990 | |
| Domain | DHC_fam | 7.61e-04 | 15 | 231 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 7.61e-04 | 15 | 231 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 7.61e-04 | 15 | 231 | 3 | IPR004273 | |
| Domain | HIN_200 | 8.99e-04 | 4 | 231 | 2 | PS50834 | |
| Domain | HSA | 8.99e-04 | 4 | 231 | 2 | SM00573 | |
| Domain | CaMBD | 8.99e-04 | 4 | 231 | 2 | PF02888 | |
| Domain | CaM-bd_dom | 8.99e-04 | 4 | 231 | 2 | IPR004178 | |
| Domain | DUF1394 | 8.99e-04 | 4 | 231 | 2 | IPR009828 | |
| Domain | CaMBD | 8.99e-04 | 4 | 231 | 2 | SM01053 | |
| Domain | HSA | 8.99e-04 | 4 | 231 | 2 | PS51204 | |
| Domain | K_chnl_Ca-activ_SK | 8.99e-04 | 4 | 231 | 2 | IPR015449 | |
| Domain | DUF1394 | 8.99e-04 | 4 | 231 | 2 | PF07159 | |
| Domain | HIN | 8.99e-04 | 4 | 231 | 2 | PF02760 | |
| Domain | HIN200/IF120x | 8.99e-04 | 4 | 231 | 2 | IPR004021 | |
| Domain | SK_channel | 8.99e-04 | 4 | 231 | 2 | PF03530 | |
| Domain | HSA_dom | 8.99e-04 | 4 | 231 | 2 | IPR014012 | |
| Domain | HSA | 8.99e-04 | 4 | 231 | 2 | PF07529 | |
| Domain | Protein_kinase_ATP_BS | HIPK1 STK32B CSNK1A1L CSNK1G1 ROCK2 GRK1 LIMK2 CSNK1A1 CSNK1D CSNK1E CSNK1G2 CSNK1G3 NLK | 9.17e-04 | 379 | 231 | 13 | IPR017441 |
| Domain | WD40/YVTN_repeat-like_dom | NBEAL1 PLXNB2 LYST PWP2 HERC1 RMC1 PLXNA1 ANAPC4 COPA RFWD3 WDR11 WDR87 | 9.91e-04 | 335 | 231 | 12 | IPR015943 |
| Domain | Gal_mutarotase_SF_dom | 1.12e-03 | 17 | 231 | 3 | IPR011013 | |
| Domain | Bromodomain | 1.21e-03 | 38 | 231 | 4 | PF00439 | |
| Domain | Kinase-like_dom | TRPM6 ATR HIPK1 STK32B CSNK1A1L CSNK1G1 ROCK2 GRK1 LIMK2 RNASEL CSNK1A1 CSNK1D CSNK1E CSNK1G2 CSNK1G3 NLK | 1.21e-03 | 542 | 231 | 16 | IPR011009 |
| Domain | WD40_repeat_dom | NBEAL1 LYST PWP2 HERC1 RMC1 ANAPC4 COPA RFWD3 TENM3 WDR11 WDR87 | 1.22e-03 | 297 | 231 | 11 | IPR017986 |
| Domain | HA2 | 1.33e-03 | 18 | 231 | 3 | SM00847 | |
| Domain | HA2 | 1.33e-03 | 18 | 231 | 3 | PF04408 | |
| Domain | Helicase-assoc_dom | 1.33e-03 | 18 | 231 | 3 | IPR007502 | |
| Domain | - | 1.34e-03 | 39 | 231 | 4 | 2.120.10.30 | |
| Domain | Munc13_dom-2 | 1.49e-03 | 5 | 231 | 2 | IPR014772 | |
| Domain | Glyco_hydro_38_C | 1.49e-03 | 5 | 231 | 2 | IPR011682 | |
| Domain | Alpha-mann_mid | 1.49e-03 | 5 | 231 | 2 | PF09261 | |
| Domain | MHD2 | 1.49e-03 | 5 | 231 | 2 | PS51259 | |
| Domain | Munc13_subgr_dom-2 | 1.49e-03 | 5 | 231 | 2 | IPR019558 | |
| Domain | Glyco_hydro_57/38_cen | 1.49e-03 | 5 | 231 | 2 | IPR028995 | |
| Domain | Glyco_hydro_38 | 1.49e-03 | 5 | 231 | 2 | PF01074 | |
| Domain | Membr_traf_MHD | 1.49e-03 | 5 | 231 | 2 | PF10540 | |
| Domain | - | 1.49e-03 | 5 | 231 | 2 | 1.20.1270.50 | |
| Domain | - | 1.49e-03 | 5 | 231 | 2 | 3.20.110.10 | |
| Domain | Alpha-mann_mid | 1.49e-03 | 5 | 231 | 2 | SM00872 | |
| Domain | Glyco_hydro_38_N | 1.49e-03 | 5 | 231 | 2 | IPR000602 | |
| Domain | Glyco_hydro_38/57_N | 1.49e-03 | 5 | 231 | 2 | IPR027291 | |
| Domain | Glyco_hydro_38_cen | 1.49e-03 | 5 | 231 | 2 | IPR015341 | |
| Domain | DUF1041 | 1.49e-03 | 5 | 231 | 2 | SM01145 | |
| Domain | Glyco_hydro_38C | 1.49e-03 | 5 | 231 | 2 | PF07748 | |
| Domain | BROMODOMAIN_2 | 1.61e-03 | 41 | 231 | 4 | PS50014 | |
| Domain | HEAT_REPEAT | 1.75e-03 | 70 | 231 | 5 | PS50077 | |
| Domain | Bromodomain | 1.77e-03 | 42 | 231 | 4 | IPR001487 | |
| Domain | BROMO | 1.77e-03 | 42 | 231 | 4 | SM00297 | |
| Domain | - | 1.77e-03 | 42 | 231 | 4 | 1.20.920.10 | |
| Domain | S_TKc | HIPK1 STK32B CSNK1A1L CSNK1G1 ROCK2 GRK1 RNASEL CSNK1A1 CSNK1D CSNK1G2 CSNK1G3 NLK | 1.78e-03 | 359 | 231 | 12 | SM00220 |
| Domain | PROTEIN_KINASE_ATP | HIPK1 STK32B CSNK1A1L CSNK1G1 ROCK2 GRK1 LIMK2 RNASEL CSNK1A1 CSNK1D CSNK1E CSNK1G2 CSNK1G3 NLK | 1.80e-03 | 459 | 231 | 14 | PS00107 |
| Domain | P-loop_NTPase | ABCA2 ATRX TDRD9 MYO6 VWA8 CARD10 DNAH14 RRAGC DHX9 ASPM HELZ DHX16 SMC2 DNAH7 DNAH12 CHD5 SMARCA2 SMARCA4 MYH15 POLQ SNRNP200 | 2.01e-03 | 848 | 231 | 21 | IPR027417 |
| Pathway | PID_P53_REGULATION_PATHWAY | 5.90e-08 | 59 | 182 | 9 | M261 | |
| Pathway | WP_HEDGEHOG_SIGNALING_WP4249 | PTCH1 CSNK1A1L CSNK1G1 CSNK1A1 CSNK1D CSNK1E CSNK1G2 CSNK1G3 | 6.52e-08 | 43 | 182 | 8 | M39706 |
| Pathway | KEGG_HEDGEHOG_SIGNALING_PATHWAY | PTCH1 CSNK1A1L CSNK1G1 CSNK1A1 CSNK1D CSNK1E CSNK1G2 CSNK1G3 | 5.54e-07 | 56 | 182 | 8 | M1053 |
| Pathway | PID_HEDGEHOG_GLI_PATHWAY | 2.51e-06 | 48 | 182 | 7 | M219 | |
| Pathway | PID_FOXO_PATHWAY | 3.76e-05 | 49 | 182 | 6 | M136 | |
| Pubmed | 7.81e-14 | 10 | 239 | 7 | 25500533 | ||
| Pubmed | Physiological role for casein kinase 1 in glutamatergic synaptic transmission. | 8.77e-11 | 6 | 239 | 5 | 16014721 | |
| Pubmed | MYO6 VWA8 INTS14 CYFIP1 AP1G1 PWP2 NCAPD2 TIMELESS ANAPC5 PTCD3 SEL1L CUL4A NUP107 COPA SMC2 WDR11 ELMO2 FANCI SNRNP200 PCID2 TP53 | 4.13e-10 | 560 | 239 | 21 | 35241646 | |
| Pubmed | Association of CPI-17 with protein kinase C and casein kinase I. | 4.70e-10 | 15 | 239 | 6 | 15003508 | |
| Pubmed | Casein kinase 1 delta (CK1delta) interacts with the SNARE associated protein snapin. | 8.09e-10 | 8 | 239 | 5 | 17101137 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | CCT3 MYO6 RPN1 ERBIN DHX9 URB1 CYFIP1 PNPLA6 AP1G1 NCAPD2 ASPM CPSF1 FAR1 NIPBL PTCD3 DHX16 NUP107 COPA FERMT1 DOCK10 VPS26A SMC2 IFI16 RLF WDR11 FANCI PES1 SMARCA2 SMARCA4 SNRNP200 PCID2 RPL9 | 1.25e-09 | 1353 | 239 | 32 | 29467282 |
| Pubmed | 1.81e-09 | 9 | 239 | 5 | 20708156 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TRPM6 ATR ATRX CCT3 MYO6 RPN1 DHX9 URB1 CYFIP1 AP1G1 PWP2 NCAPD2 CPSF1 FAR1 NIPBL PLXNA1 MGAM2 PTCD3 DHX16 NUP107 COPA SMC2 CYFIP2 STT3B CSNK1E FANCI RTRAF PES1 SMARCA4 SNRNP200 RPL9 TP53 | 4.37e-09 | 1425 | 239 | 32 | 30948266 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ABCA2 MAN2A2 MAN2A1 ATR RPN1 JAGN1 LAMA1 ADGRG1 PLXNB2 LRIG2 P3H1 TMEM106C CPSF1 TIMELESS PLXNA1 SEL1L POMT2 ROCK2 COPA CHSY1 RANBP6 TMEM38B STT3B TENM3 FANCI PES1 HTT SORL1 | 2.01e-08 | 1201 | 239 | 28 | 35696571 |
| Pubmed | ABCA2 MAN2A1 MYO6 RPN1 DHX9 PNPLA6 AP1G1 P3H1 PIK3R1 NCAPD2 HELZ PPP1R21 NUP107 COPA DOCK10 CHSY1 IFI16 CYFIP2 STT3B WDR11 CSNK1A1 CSNK1G2 FANCI CHD5 PES1 SMARCA4 RPL9 | 4.37e-08 | 1168 | 239 | 27 | 19946888 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABCA2 MAN2A2 PCNX3 VWA8 CARD10 PTCH1 PLXNB2 LYST PCNX2 URB1 SLC38A10 PNPLA6 NCAPD2 CPSF1 HERC1 PPP2R3C PLXNA1 PICK1 VPS39 CHSY1 PIKFYVE CSNK1G2 FANCI CHD5 PCNX1 HTT | 5.59e-08 | 1105 | 239 | 26 | 35748872 |
| Pubmed | BRPF3 ZMYND11 VWA8 DIS3L MDM2 INTS14 PNPLA6 SV2A PIK3R1 ASPM HELZ TAF4B FAR1 ANAPC5 ANAPC4 PTCD3 CUL4A NUP107 C16orf96 LIMK2 CHD5 SMARCA2 SMARCA4 PCID2 TP53 SORL1 | 6.79e-08 | 1116 | 239 | 26 | 31753913 | |
| Pubmed | SCFFBW7-mediated degradation of Brg1 suppresses gastric cancer metastasis. | 7.49e-08 | 7 | 239 | 4 | 30177679 | |
| Pubmed | 1.49e-07 | 8 | 239 | 4 | 16618118 | ||
| Pubmed | 1.49e-07 | 8 | 239 | 4 | 21930935 | ||
| Pubmed | 1.49e-07 | 8 | 239 | 4 | 17244647 | ||
| Pubmed | Indispensable role of Mdm2/p53 interaction during the embryonic and postnatal inner ear development. | 1.49e-07 | 8 | 239 | 4 | 28181574 | |
| Pubmed | TPP2 CCT3 URB1 PWP2 NCAPD2 CPSF1 HELZ NIPBL PTCD3 DHX16 NUP107 COPA FANCI PES1 SMARCA2 SMARCA4 SNRNP200 RPL9 TP53 | 1.60e-07 | 653 | 239 | 19 | 22586326 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | ATR CCT3 MYO6 DHX9 NCAPD2 NUP107 COPA STT3B SMARCA2 SNRNP200 TP53 | 1.76e-07 | 202 | 239 | 11 | 33005030 |
| Pubmed | TPP2 CAB39 CCT3 MYO6 RPN1 ERBIN DHX9 CYFIP1 MGAT3 CSNK1A1L PNPLA6 NRXN2 AP1G1 SACS SV2A PGAM4 PTCD3 ROCK2 COPA NT5DC3 CYFIP2 TENM4 CSNK1A1 CSNK1D RTRAF SMARCA4 SNRNP200 UNC13A PPP1R12C | 2.17e-07 | 1431 | 239 | 29 | 37142655 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | CCT3 RPN1 LAMA1 FAR1 ROCK2 COPA DOCK10 SMARCA4 POLQ DOP1A SORL1 | 2.36e-07 | 208 | 239 | 11 | 33230847 |
| Pubmed | CEP104 ATRX CCT3 RPN1 LYST ERBIN SACS H4C7 PGAM4 PWP2 NCAPD2 ASPM NIPBL PICK1 ROCK2 RPGRIP1 COPA SMC2 CYFIP2 STT3B CHD5 PES1 TENM1 MYH15 POLQ PCID2 RPL9 DOP1A CFAP46 | 2.54e-07 | 1442 | 239 | 29 | 35575683 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | CAB39 ATRX MYO6 RPN1 BIN3 DHX9 PIK3R1 PITPNA ASPM CAB39L HERC1 FAR1 PTCD3 ROCK2 RAB11FIP2 SMC2 JMJD1C CSNK1D CSNK1E FANCI PES1 TMBIM4 PRKAB2 SMARCA4 POLQ SNRNP200 PCID2 | 2.88e-07 | 1284 | 239 | 27 | 17353931 |
| Pubmed | 2.94e-07 | 129 | 239 | 9 | 23022380 | ||
| Pubmed | MAN2A2 CCT3 MYO6 RPN1 PLXNB2 DHX9 LRIG2 MGAT3 P3H1 PLXNA1 SEL1L COPA SMC2 STT3B ADGRG6 SMARCA4 SNRNP200 SORL1 | 3.01e-07 | 613 | 239 | 18 | 22268729 | |
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 21465263 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 32901886 | ||
| Pubmed | Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia. | 3.20e-07 | 3 | 239 | 3 | 24616378 | |
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 25665722 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 10734067 | ||
| Pubmed | CK1α ablation in keratinocytes induces p53-dependent, sunburn-protective skin hyperpigmentation. | 3.20e-07 | 3 | 239 | 3 | 28878021 | |
| Pubmed | Binding of p53 to the central domain of Mdm2 is regulated by phosphorylation. | 3.20e-07 | 3 | 239 | 3 | 16870621 | |
| Pubmed | Interferon-inducible protein IFIXalpha1 functions as a negative regulator of HDM2. | 3.20e-07 | 3 | 239 | 3 | 16479015 | |
| Pubmed | Nemo-like kinase is critical for p53 stabilization and function in response to DNA damage. | 3.20e-07 | 3 | 239 | 3 | 24926618 | |
| Pubmed | Cul4A physically associates with MDM2 and participates in the proteolysis of p53. | 3.20e-07 | 3 | 239 | 3 | 15548678 | |
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 17938176 | ||
| Pubmed | Proteolytic cleavage of the mdm2 oncoprotein during apoptosis. | 3.20e-07 | 3 | 239 | 3 | 9278461 | |
| Pubmed | 3.52e-07 | 22 | 239 | 5 | 31729367 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CCT3 DHX9 URB1 CSNK1A1L PER3 P3H1 ASPM TIMELESS PPP2R3C ANAPC5 NIPBL ANAPC4 PTCD3 DHX16 CUL4A NUP107 COPA HAUS2 CSNK1A1 CCNB2 CSNK1E SMARCA2 SMARCA4 SNRNP200 PPP1R12C | 4.83e-07 | 1155 | 239 | 25 | 20360068 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ATR ATRX ERBIN DHX9 PNPLA6 CPSF1 HELZ TIMELESS ANAPC5 NIPBL MOCOS DHX16 ROCK2 COPA PARG IFI16 CSNK1E SMARCA2 SMARCA4 SNRNP200 | 4.91e-07 | 774 | 239 | 20 | 15302935 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | TPP2 CCT3 MYO6 RPN1 GIN1 TMEM200A CYFIP1 NCAPD2 NIPBL PTCD3 ROCK2 COPA SMC2 CYFIP2 STT3B RTRAF SMARCA2 SMARCA4 SNRNP200 RPL9 DOP1A | 4.91e-07 | 847 | 239 | 21 | 35235311 |
| Pubmed | LYST RRAGC LRIG2 SV2A PIK3R1 TMEM106C RMC1 PLXNA1 KPNA5 TAPT1 VPS26A TMEM38B STT3B PIKFYVE VPS13D TENM1 | 5.02e-07 | 504 | 239 | 16 | 34432599 | |
| Pubmed | MAN2A1 ATRX PCNX3 ADGRG1 ERBIN URB1 CYFIP1 PNPLA6 AP1G1 ARHGEF9 PWP2 NCAPD2 HELZ FAR1 ANAPC5 NIPBL PTCD3 SEL1L CYFIP2 STT3B TEFM WDR11 CSNK1A1 CSNK1G2 RTRAF PES1 SMARCA2 PCID2 PPP1R12C | 5.47e-07 | 1497 | 239 | 29 | 31527615 | |
| Pubmed | 5.56e-07 | 102 | 239 | 8 | 10231032 | ||
| Pubmed | 5.61e-07 | 24 | 239 | 5 | 33705438 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | ATR ATRX CCT3 CARD10 DHX9 NCAPD2 CPSF1 NIPBL ROCK2 NUP107 COPA FERMT1 SMC2 FANCI SMARCA2 SMARCA4 SNRNP200 | 6.96e-07 | 582 | 239 | 17 | 20467437 |
| Pubmed | 6.98e-07 | 25 | 239 | 5 | 37451217 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | MYO6 RPN1 JAGN1 PLXNB2 URB1 PNPLA6 AP1G1 P3H1 NCAPD2 TIMELESS FAR1 ANAPC5 SEL1L NUP107 COPA CASP3 CHSY1 RANBP6 STT3B CCNB2 FANCI PES1 | 7.05e-07 | 942 | 239 | 22 | 31073040 |
| Pubmed | ATR URB1 PTPRD TIMELESS HERC1 PTCD3 SEL1L VPS39 RANBP6 RFWD3 FANCI HTT | 7.66e-07 | 285 | 239 | 12 | 32838362 | |
| Pubmed | RPN1 DHX9 P3H1 TMEM106C NCAPD2 FAR1 SEL1L NUP107 COPA RANBP6 SMC2 TMEM38B STT3B ELMO2 FANCI SMARCA4 PCNX1 SNRNP200 | 8.15e-07 | 657 | 239 | 18 | 36180527 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | ZMYND11 RPN1 JAGN1 PLXNB2 DHX9 CYFIP1 SV2A NCAPD2 TIMELESS FAR1 ANAPC4 SEL1L NUP107 IFI16 JMJD1C TMEM38B CYFIP2 STT3B RLF KIFAP3 FANCI PES1 SNRNP200 PCID2 NLK | 1.01e-06 | 1203 | 239 | 25 | 29180619 |
| Pubmed | Peli1 Modulates the Subcellular Localization and Activity of Mdmx. | 1.03e-06 | 12 | 239 | 4 | 29523541 | |
| Pubmed | 1.27e-06 | 28 | 239 | 5 | 25089626 | ||
| Pubmed | PML enhances the regulation of p53 by CK1 in response to DNA damage. | 1.28e-06 | 4 | 239 | 3 | 18246126 | |
| Pubmed | 1.28e-06 | 4 | 239 | 3 | 30487124 | ||
| Pubmed | 1.28e-06 | 4 | 239 | 3 | 38147624 | ||
| Pubmed | BAI1 Suppresses Medulloblastoma Formation by Protecting p53 from Mdm2-Mediated Degradation. | 1.28e-06 | 4 | 239 | 3 | 29894688 | |
| Pubmed | 1.28e-06 | 4 | 239 | 3 | 25825738 | ||
| Pubmed | 1.28e-06 | 4 | 239 | 3 | 21437245 | ||
| Pubmed | 1.28e-06 | 4 | 239 | 3 | 22916255 | ||
| Pubmed | All four members of the Ten-m/Odz family of transmembrane proteins form dimers. | 1.28e-06 | 4 | 239 | 3 | 12000766 | |
| Pubmed | Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues. | 1.28e-06 | 4 | 239 | 3 | 10225957 | |
| Pubmed | Dual inhibition of MDM2 and MDM4 in virus-positive Merkel cell carcinoma enhances the p53 response. | 1.28e-06 | 4 | 239 | 3 | 30598450 | |
| Pubmed | The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic. | 1.28e-06 | 4 | 239 | 3 | 32728212 | |
| Pubmed | Retinoic acid-induced survival effects in SH-SY5Y neuroblastoma cells. | 1.28e-06 | 4 | 239 | 3 | 30320919 | |
| Pubmed | Regulation of p53-MDMX interaction by casein kinase 1 alpha. | 1.28e-06 | 4 | 239 | 3 | 16024788 | |
| Pubmed | Autoactivation of the MDM2 E3 ligase by intramolecular interaction. | 1.28e-06 | 4 | 239 | 3 | 24842904 | |
| Pubmed | 1.28e-06 | 4 | 239 | 3 | 9349507 | ||
| Pubmed | 1.28e-06 | 4 | 239 | 3 | 7797465 | ||
| Pubmed | RFWD3-Mdm2 ubiquitin ligase complex positively regulates p53 stability in response to DNA damage. | 1.28e-06 | 4 | 239 | 3 | 20173098 | |
| Pubmed | Casein kinase 1α regulates an MDMX intramolecular interaction to stimulate p53 binding. | 1.28e-06 | 4 | 239 | 3 | 23028042 | |
| Pubmed | CK1alpha plays a central role in mediating MDM2 control of p53 and E2F-1 protein stability. | 1.28e-06 | 4 | 239 | 3 | 19759023 | |
| Pubmed | 2.16e-06 | 31 | 239 | 5 | 27798109 | ||
| Pubmed | 2.21e-06 | 164 | 239 | 9 | 32409323 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | ZNF131 HIPK1 MDM2 NCAPD2 DHX16 KPNA5 NUP107 COPA PARG DUSP9 CHSY1 SMC2 JMJD1C CYFIP2 RNASEL PES1 SMARCA4 SNRNP200 TP53 SORL1 | 2.33e-06 | 857 | 239 | 20 | 25609649 |
| Pubmed | CCT3 RPN1 DHX9 CYFIP1 AP1G1 PWP2 NCAPD2 NUP107 COPA SMC2 FANCI RTRAF PES1 SMARCA4 SNRNP200 RPL9 TP53 | 2.41e-06 | 638 | 239 | 17 | 33239621 | |
| Pubmed | Structural and biochemical characterization of DAXX-ATRX interaction. | 3.17e-06 | 5 | 239 | 3 | 28875283 | |
| Pubmed | CKIα ablation highlights a critical role for p53 in invasiveness control. | 3.17e-06 | 5 | 239 | 3 | 21331045 | |
| Pubmed | 3.17e-06 | 5 | 239 | 3 | 11865049 | ||
| Pubmed | DBC1 functions as a tumor suppressor by regulating p53 stability. | 3.17e-06 | 5 | 239 | 3 | 25732823 | |
| Pubmed | CLOCK gene variants associate with sleep duration in two independent populations. | 3.17e-06 | 5 | 239 | 3 | 20149345 | |
| Pubmed | 3.17e-06 | 5 | 239 | 3 | 33495326 | ||
| Pubmed | 3.17e-06 | 5 | 239 | 3 | 21680713 | ||
| Pubmed | Rad54B serves as a scaffold in the DNA damage response that limits checkpoint strength. | 3.17e-06 | 5 | 239 | 3 | 25384516 | |
| Pubmed | 3.17e-06 | 5 | 239 | 3 | 22889954 | ||
| Pubmed | Crbn I391V is sufficient to confer in vivo sensitivity to thalidomide and its derivatives in mice. | 3.17e-06 | 5 | 239 | 3 | 30064974 | |
| Pubmed | A senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism. | 3.17e-06 | 5 | 239 | 3 | 23890787 | |
| Pubmed | TRPM6 ADAM20 HIPK1 MDM2 PLXNB2 PGAM4 PLXNA1 CUL4A USP46 ADAMTS8 STT3B GRK1 GCNT7 ADAMTS6 CSNK1D CSNK1E SMARCA2 SMARCA4 | 3.57e-06 | 730 | 239 | 18 | 34857952 | |
| Pubmed | 4.03e-06 | 35 | 239 | 5 | 19389355 | ||
| Pubmed | CCT3 DHX9 PWP2 ASPM CPSF1 ANAPC5 ANAPC4 PTCD3 CUL4A COPA SMC2 TERF1 RLF WDR11 CSNK1A1 CSNK1D TENM1 UNC13C SNRNP200 RPL9 TP53 | 4.21e-06 | 971 | 239 | 21 | 33306668 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | LRIG2 CYFIP1 CSNK1A1L PTPRD HELZ FAR1 PTCD3 SEL1L KPNA5 ROCK2 DUSP9 RANBP6 VPS26A SMC2 STT3B CSNK1A1 CSNK1D CSNK1E FANCI SNRNP200 SORL1 | 4.42e-06 | 974 | 239 | 21 | 28675297 |
| Pubmed | ZNF131 ATRX MYO6 VWA8 RPN1 TTLL5 PLXNB2 ERBIN DHX9 LRIG2 URB1 PNPLA6 SACS P3H1 PIK3R1 PWP2 ASPM FAR1 PTCD3 TAPT1 NUP107 STT3B WDR11 CSNK1E PES1 SNRNP200 RPL9 | 4.61e-06 | 1487 | 239 | 27 | 33957083 | |
| Pubmed | ATR DHX9 CSNK1A1L CPSF1 NIPBL COPA SMC2 RFWD3 CSNK1A1 RTRAF SNRNP200 RPL9 | 4.75e-06 | 340 | 239 | 12 | 24332808 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | CAB39 ATR ATRX JAGN1 LYST CYFIP1 CSNK1A1L CPLANE1 ANAPC5 ANAPC4 DUSP9 CYFIP2 STT3B LIMK2 CSNK1A1 CSNK1D CCNB2 CSNK1E PRKAB2 MYH15 | 5.68e-06 | 910 | 239 | 20 | 36736316 |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | ZNF131 ATR AP1G1 NIPBL PTCD3 VPS39 FERMT1 DOCK10 IFI16 PES1 SMARCA2 SNRNP200 RPL9 | 6.09e-06 | 410 | 239 | 13 | 26949251 |
| Pubmed | Combinatorial CRISPR screen identifies fitness effects of gene paralogues. | 6.18e-06 | 186 | 239 | 9 | 33637726 | |
| Pubmed | A critical role for noncoding 5S rRNA in regulating Mdmx stability. | 6.31e-06 | 6 | 239 | 3 | 21925390 | |
| Pubmed | 6.31e-06 | 6 | 239 | 3 | 28099937 | ||
| Pubmed | The complexity of p53 modulation: emerging patterns from divergent signals. | 6.31e-06 | 6 | 239 | 3 | 9765199 | |
| Pubmed | Casein kinase I and casein kinase II differentially regulate axin function in Wnt and JNK pathways. | 6.31e-06 | 6 | 239 | 3 | 11884395 | |
| Interaction | FAXC interactions | PNPLA6 TIMELESS NIPBL VPS39 CHSY1 USP46 VPS26A SMC2 TEFM CSNK1E CSNK1G2 CSNK1G3 | 1.19e-08 | 118 | 232 | 12 | int:FAXC |
| Interaction | PPP1R14A interactions | 1.40e-07 | 22 | 232 | 6 | int:PPP1R14A | |
| Interaction | PTCH1 interactions | ABCA2 MAN2A2 MAN2A1 RPN1 LRFN3 ADGRG1 PTCH1 MDM2 PLXNB2 CSNK1A1L PLXNA1 POMT2 CHSY1 PIKFYVE CSNK1A1 | 6.86e-07 | 273 | 232 | 15 | int:PTCH1 |
| Interaction | HELQ interactions | 2.61e-06 | 20 | 232 | 5 | int:HELQ | |
| Interaction | C1orf54 interactions | ABCA2 MAN2A2 MAN2A1 LRFN3 LAMA1 PLXNB2 SLC38A10 PLXNA1 SEL1L CHSY1 TENM3 | 3.88e-06 | 167 | 232 | 11 | int:C1orf54 |
| Interaction | DBNDD2 interactions | 5.30e-06 | 11 | 232 | 4 | int:DBNDD2 | |
| Interaction | DBNDD1 interactions | 5.97e-06 | 4 | 232 | 3 | int:DBNDD1 | |
| Interaction | C9orf78 interactions | MYO6 VWA8 INTS14 CYFIP1 AP1G1 PWP2 NCAPD2 TIMELESS ANAPC5 PTCD3 SEL1L CUL4A NUP107 COPA SMC2 WDR11 ELMO2 FANCI SNRNP200 PCID2 TP53 | 1.08e-05 | 620 | 232 | 21 | int:C9orf78 |
| Interaction | HLA-DRA interactions | ABCA2 MAN2A2 LRFN3 ADGRG1 SLC38A10 TMEM106C RMC1 PLXNA1 SEL1L POMT2 | 2.34e-05 | 166 | 232 | 10 | int:HLA-DRA |
| Interaction | LRRC31 interactions | ATR CCT3 MYO6 DHX9 NCAPD2 NUP107 COPA STT3B SMARCA2 SNRNP200 TP53 | 2.69e-05 | 205 | 232 | 11 | int:LRRC31 |
| Interaction | ATL2 interactions | 2.72e-05 | 104 | 232 | 8 | int:ATL2 | |
| Interaction | MYO16 interactions | 2.79e-05 | 16 | 232 | 4 | int:MYO16 | |
| Interaction | FBXO6 interactions | ABCA2 MAN2A2 CCT3 MYO6 RPN1 ADGRG1 PLXNB2 DHX9 LRIG2 MGAT3 P3H1 PLXNA1 SEL1L POMT2 COPA SMC2 STT3B ADGRG6 TENM4 SMARCA4 SNRNP200 SORL1 | 3.03e-05 | 717 | 232 | 22 | int:FBXO6 |
| Interaction | KIF20A interactions | BRPF3 MYO6 VWA8 CARD10 ERBIN DHX9 PCNX2 URB1 CSNK1A1L H4C7 PWP2 CPSF1 HELZ HERC1 SEL1L DHX16 OTOA COPA IFI16 CSNK1A1 CSNK1D FANCI SMARCA2 SMARCA4 SNRNP200 RPL9 TP53 PPP1R12C | 3.23e-05 | 1052 | 232 | 28 | int:KIF20A |
| Interaction | WRN interactions | 4.09e-05 | 110 | 232 | 8 | int:WRN | |
| Interaction | BACH1 interactions | 4.36e-05 | 111 | 232 | 8 | int:BACH1 | |
| Interaction | POU5F1 interactions | TPP2 ATR CCT3 RPN1 LAMA1 DHX9 P3H1 NCAPD2 CPSF1 HELZ ANAPC4 PTCD3 CUL4A COPA JMJD1C FANCI CHD5 SMARCA2 SMARCA4 | 4.95e-05 | 584 | 232 | 19 | int:POU5F1 |
| Interaction | SIRT7 interactions | TPP2 ATR CCT3 MDM2 URB1 PWP2 NCAPD2 CPSF1 HELZ NIPBL PTCD3 DHX16 CUL4A NUP107 COPA FANCI PES1 SMARCA2 SMARCA4 SNRNP200 RPL9 TP53 | 5.25e-05 | 744 | 232 | 22 | int:SIRT7 |
| Interaction | PTTG1 interactions | 5.28e-05 | 114 | 232 | 8 | int:PTTG1 | |
| Interaction | CLEC12B interactions | MAN2A2 MAN2A1 JAGN1 LRFN3 PLXNB2 LRIG2 SLC38A10 PLXNA1 POMT2 CHSY1 | 5.62e-05 | 184 | 232 | 10 | int:CLEC12B |
| Interaction | H2BC21 interactions | BRPF3 ATRX MDM2 P3H1 H4C7 ANAPC5 NIPBL ANAPC4 CUL4A ROCK2 NUP107 CASQ2 USP46 SMC2 IFI16 JMJD1C RLF TENM1 SMARCA4 TP53 CFAP46 | 5.87e-05 | 696 | 232 | 21 | int:H2BC21 |
| Interaction | FKBPL interactions | 6.25e-05 | 37 | 232 | 5 | int:FKBPL | |
| Interaction | ANKRD49 interactions | 6.50e-05 | 60 | 232 | 6 | int:ANKRD49 | |
| Interaction | NYAP2 interactions | 1.28e-04 | 23 | 232 | 4 | int:NYAP2 | |
| Interaction | MRE11 interactions | BRPF3 ATR ATRX PTCH1 MDM2 DHX9 PYHIN1 DHX16 RTRAF SKA3 POLQ TP53 | 1.31e-04 | 287 | 232 | 12 | int:MRE11 |
| Interaction | ATM interactions | ATR MAS1 PTCH1 MDM2 PER3 KPNA5 TERF1 CSNK1A1 CSNK1D FANCI SMARCA4 POLQ TP53 | 1.37e-04 | 333 | 232 | 13 | int:ATM |
| Interaction | CSNK1A1 interactions | RPN1 PTCH1 MDM2 CYFIP1 CSNK1A1L CPSF1 HERC1 COPA CSNK1A1 CSNK1D CSNK1E SMARCA4 SKA3 TP53 | 1.43e-04 | 381 | 232 | 14 | int:CSNK1A1 |
| Interaction | CUL4A interactions | MAN2A1 GIN1 MDM2 DHX9 PYHIN1 CYFIP1 AP1G1 CPSF1 ANAPC5 CUL4A PPP1R21 COPA IFI16 NT5DC3 GSS PLXDC2 WDR11 CSNK1E SMARCA2 SMARCA4 SNRNP200 PCID2 TP53 | 1.44e-04 | 854 | 232 | 23 | int:CUL4A |
| Cytoband | 1p36.21 | 9.91e-07 | 63 | 239 | 6 | 1p36.21 | |
| GeneFamily | PRAME family | PRAMEF25 PRAMEF9 PRAMEF26 PRAMEF11 PRAMEF15 PRAMEF4 PRAMEF27 | 8.69e-10 | 24 | 154 | 7 | 686 |
| GeneFamily | Tachykinin receptors | 2.15e-04 | 3 | 154 | 2 | 258 | |
| GeneFamily | Dyneins, axonemal | 3.78e-04 | 17 | 154 | 3 | 536 | |
| GeneFamily | UNC13 homologs | 4.28e-04 | 4 | 154 | 2 | 836 | |
| GeneFamily | Melanocortin receptors | 7.09e-04 | 5 | 154 | 2 | 236 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 7.09e-04 | 5 | 154 | 2 | 995 | |
| GeneFamily | Mannosidases alpha class 2 | 7.09e-04 | 5 | 154 | 2 | 1194 | |
| GeneFamily | Potassium calcium-activated channels | 1.06e-03 | 6 | 154 | 2 | 255 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 1.08e-03 | 24 | 154 | 3 | 485 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily G | 1.47e-03 | 7 | 154 | 2 | 917 | |
| GeneFamily | WD repeat domain containing | 1.85e-03 | 262 | 154 | 8 | 362 | |
| GeneFamily | Glucosaminyl (N-acetyl) transferases/xylosyltransferases | 1.95e-03 | 8 | 154 | 2 | 441 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 2.50e-03 | 9 | 154 | 2 | 1230 | |
| GeneFamily | Plexins | 2.50e-03 | 9 | 154 | 2 | 683 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 3.04e-03 | 115 | 154 | 5 | 769 | |
| GeneFamily | Patatin like phospholipase domain containing | 3.10e-03 | 10 | 154 | 2 | 466 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 3.77e-03 | 11 | 154 | 2 | 1168 | |
| GeneFamily | Oligosaccharyltransferase complex subunits | 4.50e-03 | 12 | 154 | 2 | 445 | |
| GeneFamily | Anaphase promoting complex |Tetratricopeptide repeat domain containing | 6.13e-03 | 14 | 154 | 2 | 402 | |
| GeneFamily | PHD finger proteins | 7.34e-03 | 90 | 154 | 4 | 88 | |
| GeneFamily | DEAH-box helicases | 8.00e-03 | 16 | 154 | 2 | 500 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TPP2 ABCA2 MYO6 NBEAL1 TTLL5 CHN2 BIN3 ERBIN MGAT3 PER3 SV2A HELZ PRAMEF11 PPP1R21 RAB11FIP2 PRAMEF15 RANBP6 PRAMEF4 TERF1 CYFIP2 RNASEL PLXDC2 SMARCA2 PCNX1 ARHGAP28 HTT SORL1 | 4.02e-06 | 1124 | 237 | 27 | MM1070 |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | TPP2 ZNF131 BRPF3 HIPK1 AP1G1 PIK3R1 RMC1 KPNA5 CUL4A RAB11FIP2 CASP3 KBTBD2 JMJD1C STT3B GCNT7 CSNK1A1 CSNK1D CSNK1E CSNK1G3 SORL1 | 4.27e-06 | 680 | 237 | 20 | M41089 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | CAB39 MAN2A2 ATR ATRX HIPK1 LYST ERBIN DHX9 PYHIN1 PCNX2 SACS PIK3R1 DENND4B HELZ HERC1 NIPBL DOCK10 CHSY1 VPS26A KBTBD2 IFI16 JMJD1C CYFIP2 STT3B PIKFYVE ELMO2 CSNK1G2 SMARCA2 PCNX1 SNRNP200 RPL9 SORL1 | 5.22e-06 | 1492 | 237 | 32 | M40023 |
| Coexpression | GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_DN | PTCH1 DHX9 PCNX2 KCNN3 HERC1 PTCD3 CUL4A CYFIP2 VPS13D OR11A1 | 1.39e-05 | 198 | 237 | 10 | M5507 |
| Coexpression | GSE22886_NAIVE_TCELL_VS_NKCELL_DN | 1.39e-05 | 198 | 237 | 10 | M4415 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | ZNF131 ATR ATRX DHX9 ASPM FAR1 PPP2R3C NIPBL MOCOS SEL1L NUP107 COPA SMC2 IFI16 RLF CSNK1A1 CSNK1D CSNK1G3 SKA3 | 3.40e-05 | 721 | 237 | 19 | M10237 |
| Coexpression | GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNG_KO_DN | 4.25e-05 | 140 | 237 | 8 | M2910 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TPP2 ABCA2 MYO6 NBEAL1 TTLL5 CHN2 BIN3 ERBIN MGAT3 PER3 SV2A HELZ PPP1R21 RAB11FIP2 RANBP6 TERF1 CYFIP2 RNASEL PLXDC2 SMARCA2 PCNX1 ARHGAP28 HTT SORL1 | 6.78e-05 | 1102 | 237 | 24 | M2369 |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | CAB39 ZMYND11 MAN2A2 MAN2A1 ATRX CCT3 ADGRG1 ERBIN DHX9 PITPNA PWP2 CPSF1 ANAPC5 CUL4A NUP107 COPA CASP3 VPS26A SMC2 TERF1 GSS KIFAP3 WDR11 CSNK1A1 CSNK1D CSNK1G3 SMARCA2 NLK | 7.17e-05 | 1399 | 237 | 28 | M535 |
| Coexpression | CHICAS_RB1_TARGETS_GROWING | ATRX TMEM106C ASPM TIMELESS DOCK10 SMC2 IFI16 ADGRG6 ADAMTS6 CCNB2 | 7.64e-05 | 242 | 237 | 10 | M2128 |
| Coexpression | GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_UP | 8.48e-05 | 198 | 237 | 9 | M5586 | |
| Coexpression | GSE41867_DAY15_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP | 8.81e-05 | 199 | 237 | 9 | M9523 | |
| Coexpression | GSE3982_MAST_CELL_VS_MAC_UP | 8.81e-05 | 199 | 237 | 9 | M5429 | |
| Coexpression | GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_STIM_DN | 9.15e-05 | 200 | 237 | 9 | M8001 | |
| Coexpression | GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_UP | 9.15e-05 | 200 | 237 | 9 | M8308 | |
| Coexpression | GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_DN | 9.15e-05 | 200 | 237 | 9 | M7174 | |
| Coexpression | GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_MINERALCORTICOID_REC_KO_DN | 9.15e-05 | 200 | 237 | 9 | M7744 | |
| Coexpression | GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN | 9.15e-05 | 200 | 237 | 9 | M3188 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ATRX LYST ERBIN DHX9 PYHIN1 NIPBL ROCK2 PARG DOCK10 CASP3 JMJD1C | 5.09e-09 | 184 | 239 | 11 | 1154a5ad7b8512272b7476f949ddac350910bfb7 |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | TMEM200A LRIG2 URB1 DENND4B FAR1 UTY SEL1L RAB11FIP2 DOCK10 POLQ | 6.65e-08 | 185 | 239 | 10 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.65e-08 | 185 | 239 | 10 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4/8-lo-Cycling_T|blood / Manually curated celltypes from each tissue | TMEM106C NCAPD2 ASPM TIMELESS FERMT1 SMC2 CCNB2 FANCI SKA3 POLQ | 7.73e-08 | 188 | 239 | 10 | 714ccbcf826f26d39757931a3b8abbd952f4cddc |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c14-MKI67-CCL5_h|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | TMEM106C NCAPD2 ASPM TIMELESS SMC2 RFWD3 CCNB2 FANCI SKA3 POLQ | 9.89e-08 | 193 | 239 | 10 | cf680afddc08b6481f1b3eee9c57acfaebeac6f0 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | TMEM106C NCAPD2 ASPM TIMELESS SMC2 RFWD3 CCNB2 FANCI SKA3 POLQ | 1.04e-07 | 194 | 239 | 10 | f9070035553bc68106a9e0bdf4b507715a138aba |
| ToppCell | facs-Trachea-nan-3m|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ERBIN SLC38A10 PIK3R1 ANAPC5 ROCK2 COPA JMJD1C STT3B PLXDC2 CSNK1A1 | 1.20e-07 | 197 | 239 | 10 | 0353d925ee4b7aefc2c51b5fab873f465cdf9ebc |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | TMEM106C NCAPD2 ASPM TIMELESS SMC2 RFWD3 CCNB2 FANCI SKA3 POLQ | 1.20e-07 | 197 | 239 | 10 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 |
| ToppCell | distal-3-Hematologic-Proliferating_NK/T|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | TMEM106C NCAPD2 ASPM TIMELESS SMC2 CCNB2 CSNK1E FANCI SKA3 POLQ | 1.26e-07 | 198 | 239 | 10 | aa23119d73554733981df474648e59918d04edfc |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4/8-lo-Cycling_T|Lung / Manually curated celltypes from each tissue | 4.87e-07 | 176 | 239 | 9 | a40dfd8c4ba16757ff929b2f03a0628acf334de4 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.16e-07 | 181 | 239 | 9 | 3fe648db1cb8326066d8bde3ca1287c5c9af19bd | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-07 | 182 | 239 | 9 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4/8-lo|blood / Manually curated celltypes from each tissue | 7.39e-07 | 185 | 239 | 9 | df85ff34b796b403f2d0741771e9592e03657f6a | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 7.73e-07 | 186 | 239 | 9 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.01e-06 | 192 | 239 | 9 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.10e-06 | 194 | 239 | 9 | f39a471293ecc5c5967b00e772b8f48ebc9affbe | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.10e-06 | 194 | 239 | 9 | a75ecd0b0a928d4646602f7d16a645f6b3df3af5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.10e-06 | 194 | 239 | 9 | 17744fd6645cf5a447a01a83f07e8d305c2bcd9c | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.10e-06 | 194 | 239 | 9 | e14f66f7584909621b776292fbd52808273fd2ee | |
| ToppCell | Control-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class | 1.10e-06 | 194 | 239 | 9 | 9bbb124001fba7450f4639f47f9b720a483e7242 | |
| ToppCell | Influenza_Severe-T/NK_proliferative|World / Disease group and Cell class | 1.15e-06 | 195 | 239 | 9 | 6f079c2d7d08110a5e1822ea861b8037eb3f62c9 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.20e-06 | 196 | 239 | 9 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | facs-Trachea-3m|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | ERBIN SLC38A10 PIK3R1 ROCK2 COPA JMJD1C STT3B PLXDC2 CSNK1A1 | 1.25e-06 | 197 | 239 | 9 | e77016d64b1cac9825fec7cfe5071f1567401187 |
| ToppCell | Healthy-T/NK_proliferative|World / disease group, cell group and cell class | 1.25e-06 | 197 | 239 | 9 | e90be1e7e02f736b6aab14010a912b592d6f1e80 | |
| ToppCell | (3)_MNP-(3)_Macrophage_Dividing|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.25e-06 | 197 | 239 | 9 | 048bc4f8fd5d4f394e2384700640f72042336597 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.25e-06 | 197 | 239 | 9 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.25e-06 | 197 | 239 | 9 | bd9d57e0c873f6526dca322f4dad8e6bd692586c | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class | 1.30e-06 | 198 | 239 | 9 | bf0131fbca6032e1aab4aa807f8c1d3be689cb7f | |
| ToppCell | (1)_T_cell_dividing|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.30e-06 | 198 | 239 | 9 | dac3a16e3a070a37f4d0ea37633c23fdc8a9c70a | |
| ToppCell | distal-Hematologic-Proliferating_NK/T-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.30e-06 | 198 | 239 | 9 | 5c14b152912429f099dfcb6bcb1aec80314a3284 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|COVID-19_Moderate / disease group, cell group and cell class | 1.30e-06 | 198 | 239 | 9 | 166c000fb0e19602ffdd8bf2b2f19be2c6df96a6 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.30e-06 | 198 | 239 | 9 | 6981cd5b1585c8ae6febdf0c4fb83067127f106c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.36e-06 | 199 | 239 | 9 | e98ff036d04fc78dffef156bdc0d644532274067 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.36e-06 | 199 | 239 | 9 | 305a9ade5bbe8e981e7c641c9a5e0c9f8ef60470 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Severe / Disease group, lineage and cell class | 1.36e-06 | 199 | 239 | 9 | ddae7fe7633661f15d3c79f5187415ffbfecce67 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.36e-06 | 199 | 239 | 9 | 7feedb0bf84a3361c8ab5b6674ff64e8ff140c23 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.36e-06 | 199 | 239 | 9 | 123fbf2122aa221d8cbf3aef9361ba0982c07695 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.36e-06 | 199 | 239 | 9 | fba48342066aab41a8bcb20db40a6df0158e1cbe | |
| ToppCell | distal-Hematologic-Proliferating_NK/T|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.36e-06 | 199 | 239 | 9 | 4f02e03c118744fba0dfc5e3ed6dea4041f3d089 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.36e-06 | 199 | 239 | 9 | 6b1304417cf9c44ca70d2bfc2b5acc1a206f25b6 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.36e-06 | 199 | 239 | 9 | 616c04b0605907fb218263f2164c36cb2fa26b87 | |
| ToppCell | (1)_T_cells-(1)_T_cell_dividing|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.36e-06 | 199 | 239 | 9 | 33afdd1b1b951b360ababf440bc556fd9e1c1db2 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.41e-06 | 200 | 239 | 9 | 3835a8a9739b8cd5bf19c40765ef76907ac1ad38 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-T/NK_proliferative|COVID-19_Mild / Disease, condition lineage and cell class | 1.41e-06 | 200 | 239 | 9 | 6126a3bbafe2110fba0c1c4493035df4e8193d22 | |
| ToppCell | mild-T/NK_proliferative|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.41e-06 | 200 | 239 | 9 | 25b4a1a33348e274bd4457efc0d6faa5421c3d31 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_NK-Cycling_NK|Lung / Manually curated celltypes from each tissue | 1.41e-06 | 200 | 239 | 9 | 381bafdde6492f020ae93ab8fffa6215c631c570 | |
| ToppCell | Biopsy_Other_PF-Immune-Proliferating_Macrophages|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.41e-06 | 200 | 239 | 9 | 61473e8613f39a92002d5b631e6bd563735566e4 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.41e-06 | 200 | 239 | 9 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 | |
| ToppCell | BL-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.41e-06 | 200 | 239 | 9 | 04d95a9102248e98eed069840ea6d3d23a243fd5 | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.41e-06 | 200 | 239 | 9 | f6b5320cdfe640a71e6e2df26f30d42e64b1c921 | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD8_T_cells|Lymphoid / Condition, Lineage and Cell class | 1.41e-06 | 200 | 239 | 9 | 4556bb626ca1a00a6db13d2adb35acb8ba848f9c | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.41e-06 | 200 | 239 | 9 | 9775ca7dedb76fcbb74f80f86b33c94e394c320a | |
| ToppCell | Control-Control-Lymphocyte-T/NK-T/NK_proliferative|Control / Disease, condition lineage and cell class | 1.41e-06 | 200 | 239 | 9 | 6cf63dd57f6bc0c42e7182322dd24ff9afbe9186 | |
| ToppCell | Biopsy_IPF-Epithelial-Proliferating_Epithelial_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 1.41e-06 | 200 | 239 | 9 | 63c5402f050fdb12abab3c8b7f33d4914ae26b9b | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-T/NK_proliferative|COVID-19_Severe / Disease, condition lineage and cell class | 1.41e-06 | 200 | 239 | 9 | 0892603e604c2a945dd720685d45970f855bd5d3 | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.41e-06 | 200 | 239 | 9 | e4eb915c29909cf8535a3603c68976545c05e54b | |
| ToppCell | Severe-Developping_Plasmablast|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.41e-06 | 200 | 239 | 9 | 6d0cd00e52568d23597cc2a4059bd967d7d2dab5 | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte-|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.41e-06 | 200 | 239 | 9 | 415e7556b5ac45688e2c6c30a52bd40e0eb27c7d | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.41e-06 | 200 | 239 | 9 | 04bf9e6a0fbd792b49eed63dabba5d6fafed8c07 | |
| ToppCell | Severe-T/NK_proliferative|World / Disease group and Cell class | 1.41e-06 | 200 | 239 | 9 | 128d82eb4d5760adf872212d8e8b5787a889969f | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 1.41e-06 | 200 | 239 | 9 | cfec2f712b870797fab3b0770f16feaafd37e8d5 | |
| ToppCell | (3)_MNP-(3)_DC_Monocyte_Dividing|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.41e-06 | 200 | 239 | 9 | d94fe9bd6ee7c1fed14666f24de41bda014e299b | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.16e-06 | 165 | 239 | 8 | 242bdb7654f415391fb8e9bdc06412c7eee9c97e | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.16e-06 | 165 | 239 | 8 | 436ce4bc75e1ba4351c439ccad19f84ad5bcb92f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.88e-06 | 175 | 239 | 8 | e5467dacf81f1f913b1719931cf1a7331434a7e7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.88e-06 | 175 | 239 | 8 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | Dividing_Macrophages-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 5.53e-06 | 178 | 239 | 8 | 1893fadac2ec3d5de0a641e57b7b2f962012a9ba | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-06 | 179 | 239 | 8 | e880c507f11ce75d104593a4ca29f0295f8125e8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.51e-06 | 182 | 239 | 8 | 336cd05e46a741185ce3c59ee67a4b07fa6a5101 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.51e-06 | 182 | 239 | 8 | 39f9b3eb22293cc27c6e175702c77d1eeb24fdc9 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Cycling_T|Liver / Manually curated celltypes from each tissue | 6.51e-06 | 182 | 239 | 8 | 81557cdc88777f3bd4e1dd18a760b08fc29122ef | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.34e-06 | 185 | 239 | 8 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | Dividing_Macrophages-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.64e-06 | 186 | 239 | 8 | 0067eb78d4c7e32b9563550d9fcaf13445ee6a48 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 7.94e-06 | 187 | 239 | 8 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.94e-06 | 187 | 239 | 8 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK-Cycling_NK|Liver / Manually curated celltypes from each tissue | 8.26e-06 | 188 | 239 | 8 | 5eb94e652a734c6f15c68a178e9d05f0febcf34c | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 8.26e-06 | 188 | 239 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | normal-na-Lymphocytic|normal / PBMC cell types (v2) per disease, treatment status, and sex | 8.58e-06 | 189 | 239 | 8 | 1d382f8eb998c6a30e09fddc9a427afc8f5f7323 | |
| ToppCell | normal-na-Lymphocytic-lymphocyte|normal / PBMC cell types (v2) per disease, treatment status, and sex | 8.58e-06 | 189 | 239 | 8 | b83fd81ecc5ef363be7435ee12cb7079e2434af7 | |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 8.58e-06 | 189 | 239 | 8 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa | |
| ToppCell | normal-na-Lymphocytic-lymphocyte-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 8.58e-06 | 189 | 239 | 8 | 3db4177d68cab4cd16842d2ebcaca28f69300e44 | |
| ToppCell | Dividing_Macrophages-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 8.58e-06 | 189 | 239 | 8 | d4e88a3e50499d683e3db38aee04490146fe30bb | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 8.92e-06 | 190 | 239 | 8 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Undetermined|normal_Pleural_Fluid / Location, Cell class and cell subclass | 8.92e-06 | 190 | 239 | 8 | 165c61443ff0c8efbdad3b052bb00f46d81c5203 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 8.92e-06 | 190 | 239 | 8 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 8.92e-06 | 190 | 239 | 8 | 451eaceb0cb0ec6cfcae00253c0e5c92a168c2f3 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.27e-06 | 191 | 239 | 8 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Cycling_T|GI_small-bowel / Manually curated celltypes from each tissue | 9.27e-06 | 191 | 239 | 8 | e642fa7395c05fb53324c9d46bbc52f89fc9673f | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.27e-06 | 191 | 239 | 8 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | Dividing_Macrophages-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 9.27e-06 | 191 | 239 | 8 | 3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 9.27e-06 | 191 | 239 | 8 | 210a0f1a71df2508cbfc73d6868a2122338b9a1c | |
| ToppCell | (3)_Macrophage_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 9.27e-06 | 191 | 239 | 8 | b42f0b89bb94fd43786ff50f1caeb3ebfbbb43fd | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.27e-06 | 191 | 239 | 8 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | Dividing_Macrophages-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 9.63e-06 | 192 | 239 | 8 | 741bd0c2b0a7ce3fcb1610ce8bdacaf9a803c212 | |
| ToppCell | control-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.00e-05 | 193 | 239 | 8 | ecb4018a47d9a82bb999e0bc8b3dceabd97d1f0d | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.04e-05 | 194 | 239 | 8 | 17af04acd54dd6a895a966cbb4422de25dc4f1e6 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Cycling_Myeloid-Mac|Lung / Manually curated celltypes from each tissue | 1.04e-05 | 194 | 239 | 8 | a8ae49157ca3f9e8b3f1750a995aee012dc859b6 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.04e-05 | 194 | 239 | 8 | 3c385d93c5fe1a7817813c492f79fdb94d887357 | |
| ToppCell | Control-Lymphocyte-T_NK-T_NK_proliferative|Control / Disease, Lineage and Cell Type | 1.04e-05 | 194 | 239 | 8 | 844731b7943d1cfca819b7b89e4e62067bfa0230 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-05 | 194 | 239 | 8 | a12b64945e10f00aa983678a02586c59badc1570 | |
| Computational | Neighborhood of RFC4 | 1.14e-04 | 60 | 138 | 6 | GNF2_RFC4 | |
| Computational | Neighborhood of RFC3 | 1.68e-04 | 41 | 138 | 5 | GNF2_RFC3 | |
| Drug | CKI-8 | 1.29e-12 | 10 | 234 | 7 | CID000486026 | |
| Drug | di-t-butylphosphite | 1.29e-12 | 10 | 234 | 7 | CID000518693 | |
| Drug | 2-amino-5-(N-ethylcarboxyamido)-pentanoic acid | 1.29e-12 | 10 | 234 | 7 | CID000194789 | |
| Drug | Asptpsa | 1.29e-12 | 10 | 234 | 7 | CID000132853 | |
| Drug | IC 261 | 7.67e-12 | 7 | 234 | 6 | ctd:C411652 | |
| Drug | 5-chloroisoquinoline | 1.80e-11 | 13 | 234 | 7 | CID000224933 | |
| Drug | AC1Q5W8U | 6.64e-11 | 15 | 234 | 7 | CID000006483 | |
| Drug | anthraquinone | PTCH1 CSNK1A1L CSNK1G1 WDR11 CSNK1A1 CSNK1D CSNK1E CSNK1G2 CSNK1G3 | 1.03e-08 | 60 | 234 | 9 | CID000006780 |
| Drug | S-ethylcysteine | 1.09e-08 | 28 | 234 | 7 | CID000030993 | |
| Drug | diisopropylphosphate | 1.84e-08 | 30 | 234 | 7 | CID000074162 | |
| Drug | NG97 | 1.84e-08 | 30 | 234 | 7 | CID006604931 | |
| Drug | cKP | 1.84e-08 | 30 | 234 | 7 | CID005494415 | |
| Drug | Pp55 | 4.09e-08 | 50 | 234 | 8 | CID000132900 | |
| Drug | CKI-7 | 6.57e-08 | 53 | 234 | 8 | CID000129236 | |
| Drug | NSC401575 | CSNK1A1L CSNK1G1 TERF1 RNASEL CSNK1A1 CSNK1D CSNK1E CSNK1G2 CSNK1G3 SMARCA4 TP53 | 9.80e-08 | 129 | 234 | 11 | CID000003165 |
| Drug | styryl sulfone | 1.61e-07 | 6 | 234 | 4 | CID000260148 | |
| Drug | AC1L1GFH | 2.60e-07 | 43 | 234 | 7 | CID000003660 | |
| Drug | CK2 inhibitor | CSNK1A1L CSNK1G1 CASP3 TERF1 CSNK1A1 CSNK1D CSNK1E CSNK1G2 CSNK1G3 | 2.81e-07 | 87 | 234 | 9 | CID000001694 |
| Drug | 6-hydroxymethyl-7,8-dihydropterin | 3.07e-07 | 44 | 234 | 7 | CID000000218 | |
| Drug | geldanamycin | TPP2 CAB39 ZMYND11 ATRX MDM2 DHX9 PTPRD PIK3R1 ASPM NIPBL ROCK2 CASP3 KBTBD2 JMJD1C SMARCA2 TP53 HTT | 3.31e-07 | 371 | 234 | 17 | ctd:C001277 |
| Drug | cnicin | CSNK1A1L PIK3R1 CSNK1G1 PIKFYVE CSNK1A1 CSNK1D CSNK1E CSNK1G2 CSNK1G3 | 4.54e-07 | 92 | 234 | 9 | CID000091176 |
| Drug | VX-680 | 6.56e-07 | 31 | 234 | 6 | CID005494449 | |
| Drug | NSC-364372 | HDAC8 MDM2 CSNK1A1L PER3 CSNK1G1 TAF4B KPNA5 DUSP9 CASP3 LIMK2 CSNK1A1 CSNK1D CCNB2 CSNK1E CSNK1G2 FANCI CSNK1G3 TP53 HTT | 7.03e-07 | 484 | 234 | 19 | CID000435143 |
| Drug | PI-103 | 8.01e-07 | 32 | 234 | 6 | CID009884685 | |
| Drug | NS-398; Up 200; 10uM; PC3; HT_HG-U133A | CEP104 MYO6 PTCH1 LYST URB1 MGAT3 PER3 KCNN1 PICK1 POMT2 OPRL1 KDM7A | 1.05e-06 | 198 | 234 | 12 | 6892_UP |
| Drug | mazindol | CSNK1A1L PTPRD CSNK1G1 CSNK1A1 CSNK1D CSNK1E CSNK1G2 CSNK1G3 | 1.14e-06 | 76 | 234 | 8 | CID000004020 |
| Drug | emodin | CSNK1A1L CSNK1G1 ROCK2 CASP3 CSNK1A1 CSNK1D CCNB2 CSNK1E CSNK1G2 CSNK1G3 | 2.21e-06 | 142 | 234 | 10 | CID000003220 |
| Drug | methylglyoxal bis(guanylhydrazone | 3.01e-06 | 61 | 234 | 7 | CID000009991 | |
| Drug | Domperidone maleate; Up 200; 7.4uM; HL60; HT_HG-U133A | MDM2 LYST PER3 PIK3R1 CSNK1G1 SEL1L FERMT1 TMEM38B CSNK1A1 ELMO2 CSNK1E | 5.38e-06 | 193 | 234 | 11 | 1301_UP |
| Drug | Memantine Hydrochloride [41100-52-1]; Down 200; 18.6uM; MCF7; HT_HG-U133A | CEP104 ABCA2 MAN2A2 PTCH1 LYST PNPLA6 CSNK1G1 VPS39 LIMK2 TENM3 CSNK1E | 5.65e-06 | 194 | 234 | 11 | 7354_DN |
| Drug | troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A_EA | HIPK1 ERBIN PIK3R1 RABGGTA ROCK2 USP46 TMEM38B RLF VPS13D PCNX1 SORL1 | 6.87e-06 | 198 | 234 | 11 | 1070_DN |
| Drug | rutin | CSNK1A1L CSNK1G1 CASP3 CSNK1A1 CSNK1D CSNK1E CSNK1G2 CSNK1G3 | 7.85e-06 | 98 | 234 | 8 | CID005280805 |
| Drug | 2,3-DPG | CSNK1A1L CSNK1G1 PGAM4 ASPM CSNK1A1 CSNK1D CSNK1E CSNK1G2 CSNK1G3 | 1.26e-05 | 137 | 234 | 9 | CID000000061 |
| Drug | spermine | MYO6 PTCH1 CSNK1A1L PIK3R1 CSNK1G1 ASPM CASP3 STT3B PIKFYVE CSNK1A1 CSNK1D CSNK1E CSNK1G2 CSNK1G3 POLQ | 1.54e-05 | 394 | 234 | 15 | CID000001103 |
| Drug | Seneciphylline [480-81-9]; Down 200; 12uM; MCF7; HT_HG-U133A | LRFN3 MDM2 DHX9 ANAPC5 NPY5R COPA CASP3 CSNK1A1 CSNK1E SMARCA2 | 2.75e-05 | 189 | 234 | 10 | 2797_DN |
| Drug | Estradiol-17 beta [50-28-2]; Down 200; 14.6uM; PC3; HT_HG-U133A | ZMYND11 TTLL5 CSNK1G1 TAF4B KPNA5 POMT2 ROCK2 VPS13D SMARCA2 PCNX1 | 2.87e-05 | 190 | 234 | 10 | 6718_DN |
| Drug | Butylparaben [94-26-8]; Down 200; 20.6uM; PC3; HT_HG-U133A | VWA8 CSNK1G1 ARHGEF9 ANAPC5 COPA LIMK2 SMARCA2 SMARCA4 PCNX1 ARHGAP28 | 3.00e-05 | 191 | 234 | 10 | 4647_DN |
| Drug | rottlerin; Down 200; 10uM; MCF7; HT_HG-U133A_EA | PER3 PIK3R1 PLXNA1 SEL1L RANBP6 SMC2 RFWD3 LIMK2 CSNK1E POLQ | 3.00e-05 | 191 | 234 | 10 | 941_DN |
| Drug | Cys-cys | CSNK1A1L CSNK1G1 RABGGTA CSNK1A1 CSNK1D CSNK1E CSNK1G2 CSNK1G3 | 3.25e-05 | 119 | 234 | 8 | CID000152238 |
| Drug | D-cycloserine [68-41-7]; Down 200; 39.2uM; MCF7; HT_HG-U133A | HIPK1 PTCH1 DHX9 PIK3R1 TIMELESS ROCK2 RFWD3 RNASEL PRKAB2 TP53 | 3.28e-05 | 193 | 234 | 10 | 3562_DN |
| Drug | AG-028671 [847803-03-6]; Up 200; 10uM; MCF7; HT_HG-U133A | ZMYND11 LRFN3 MDM2 LYST DHX9 ANAPC5 GSTA4 LIMK2 RNASEL ELMO2 | 3.28e-05 | 193 | 234 | 10 | 6587_UP |
| Drug | TDP 521252 | 3.64e-05 | 7 | 234 | 3 | ctd:C508490 | |
| Drug | EUK-134 | 3.73e-05 | 19 | 234 | 4 | ctd:C433928 | |
| Drug | Practolol [6673-35-4]; Down 200; 15uM; HL60; HG-U133A | FAXDC2 DHX9 NCAPD2 NIPBL SEL1L CUL4A LIMK2 SMARCA2 SMARCA4 PCID2 | 3.91e-05 | 197 | 234 | 10 | 1587_DN |
| Drug | Esculin Hydrate [531-75-9]; Up 200; 11.8uM; PC3; HT_HG-U133A | MAN2A2 DHX9 PCNX2 TIMELESS ANAPC5 RABGGTA SEL1L DNAH7 VPS13D SMARCA2 | 3.91e-05 | 197 | 234 | 10 | 6310_UP |
| Drug | Methantheline bromide [53-46-3]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 4.08e-05 | 198 | 234 | 10 | 6254_UP | |
| Drug | Oxytetracycline dihydrate [6153-64-6]; Down 200; 8uM; HL60; HG-U133A | PWP2 NIPBL PLXNA1 SEL1L TMEM38B VPS13D CSNK1E PES1 SMARCA2 SMARCA4 | 4.08e-05 | 198 | 234 | 10 | 1553_DN |
| Drug | K00014 | 4.18e-05 | 38 | 234 | 5 | CID000004987 | |
| Drug | (R)-(+)-Atenolol [56715-13-0]; Down 200; 15uM; MCF7; HT_HG-U133A | MAN2A2 PER3 ARHGEF9 HELZ TIMELESS VPS39 FERMT1 SMARCA4 PCNX1 NLK | 4.44e-05 | 200 | 234 | 10 | 4841_DN |
| Drug | Ethylnitrosourea | ATRX MYO6 MC3R MC4R MDM2 NTS CASP3 OPRL1 POLQ DISP1 TP53 HTT | 5.16e-05 | 291 | 234 | 12 | ctd:D005038 |
| Drug | IC261 | 6.07e-05 | 96 | 234 | 7 | CID000003674 | |
| Drug | spermidine | MYO6 CSNK1A1L CSNK1G1 ASPM STT3B CSNK1A1 CSNK1D CSNK1E CSNK1G2 CSNK1G3 POLQ | 6.62e-05 | 253 | 234 | 11 | CID000001102 |
| Drug | AC1L1IHP | NOX5 CSNK1A1L PTPRD PIK3R1 CSNK1G1 PPP2R3C ROCK2 CASP3 TERF1 GSS PIKFYVE CSNK1A1 CSNK1D CCNB2 CSNK1E CSNK1G2 CSNK1G3 TP53 NLK PPP1R12C | 6.88e-05 | 728 | 234 | 20 | CID000004584 |
| Drug | sulfonamide analog 1 | MDM2 CSNK1A1L CSNK1G1 CASP3 TERF1 CSNK1A1 CSNK1D CSNK1E CSNK1G2 CSNK1G3 | 7.53e-05 | 213 | 234 | 10 | CID005327336 |
| Drug | Substance P Octapeptide | 8.26e-05 | 23 | 234 | 4 | CID000171298 | |
| Drug | Flavanones | 9.83e-05 | 24 | 234 | 4 | ctd:D044950 | |
| Drug | 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000) | 1.05e-04 | 2 | 234 | 2 | ctd:C519184 | |
| Drug | 3-(4-chlorophenyl)-3-(4-hydroxy-3,5-dimethoxybenzyloxy)-2-propyl-2,3-dihydroisoindol-1-one | 1.05e-04 | 2 | 234 | 2 | ctd:C501634 | |
| Drug | MI-219 | 1.05e-04 | 2 | 234 | 2 | ctd:C574930 | |
| Drug | senktide | 1.05e-04 | 2 | 234 | 2 | ctd:C054724 | |
| Drug | SureCN3295164 | 1.05e-04 | 2 | 234 | 2 | CID012424014 | |
| Drug | SHU 9119 | 1.05e-04 | 2 | 234 | 2 | ctd:C103272 | |
| Drug | talnetant | 1.16e-04 | 25 | 234 | 4 | CID000133090 | |
| Drug | Uperolein | 1.22e-04 | 10 | 234 | 3 | CID003085088 | |
| Drug | 2,2-bis(hydroxymethyl)-1-azabicyclo(2,2,2,)octan-3-one | 1.22e-04 | 10 | 234 | 3 | ctd:C451219 | |
| Disease | syndromic X-linked intellectual disability Najm type (implicated_via_orthology) | 1.19e-07 | 7 | 228 | 4 | DOID:0060807 (implicated_via_orthology) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.25e-05 | 195 | 228 | 9 | DOID:1574 (implicated_via_orthology) | |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 7.09e-05 | 29 | 228 | 4 | C0496920 | |
| Disease | Ovarian Carcinoma | 8.13e-05 | 30 | 228 | 4 | C0029925 | |
| Disease | Osteogenesis Imperfecta | 1.23e-04 | 13 | 228 | 3 | C0029434 | |
| Disease | Adenoid Cystic Carcinoma | 1.30e-04 | 100 | 228 | 6 | C0010606 | |
| Disease | chromosome 15q11.2 deletion syndrome (implicated_via_orthology) | 1.77e-04 | 3 | 228 | 2 | DOID:0060393 (implicated_via_orthology) | |
| Disease | Advanced Sleep-Phase Syndrome, Familial | 1.77e-04 | 3 | 228 | 2 | C1858496 | |
| Disease | advanced sleep phase syndrome (is_implicated_in) | 3.53e-04 | 4 | 228 | 2 | DOID:0050628 (is_implicated_in) | |
| Disease | Li-Fraumeni Syndrome | 3.53e-04 | 4 | 228 | 2 | C0085390 | |
| Disease | coagulation factor measurement | 4.71e-04 | 20 | 228 | 3 | EFO_0004634 | |
| Disease | Sarcoma | 5.46e-04 | 21 | 228 | 3 | C1261473 | |
| Disease | prothrombin time measurement | 5.46e-04 | 21 | 228 | 3 | EFO_0008390 | |
| Disease | Glioma | 5.82e-04 | 87 | 228 | 5 | C0017638 | |
| Disease | JOUBERT SYNDROME 17 | 5.85e-04 | 5 | 228 | 2 | C3553264 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 5.85e-04 | 5 | 228 | 2 | C3281201 | |
| Disease | Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome | 5.85e-04 | 5 | 228 | 2 | C0263859 | |
| Disease | dilated cardiomyopathy (biomarker_via_orthology) | 6.29e-04 | 22 | 228 | 3 | DOID:12930 (biomarker_via_orthology) | |
| Disease | age at menarche | ZNF131 MYO6 MC3R MC4R BRINP1 SLC38A10 PTPRD TACR3 ANAPC4 KBTBD2 CYFIP2 SMARCA2 UNC13C | 7.82e-04 | 594 | 228 | 13 | EFO_0004703 |
| Disease | De Lange syndrome | 8.74e-04 | 6 | 228 | 2 | cv:C0270972 | |
| Disease | retinopathy, type 2 diabetes mellitus | 8.74e-04 | 6 | 228 | 2 | EFO_0003839, MONDO_0005148 | |
| Disease | Cornelia de Lange syndrome (implicated_via_orthology) | 8.74e-04 | 6 | 228 | 2 | DOID:11725 (implicated_via_orthology) | |
| Disease | breast cancer (implicated_via_orthology) | 9.24e-04 | 25 | 228 | 3 | DOID:1612 (implicated_via_orthology) | |
| Disease | Alcoholic Intoxication, Chronic | 1.20e-03 | 268 | 228 | 8 | C0001973 | |
| Disease | tissue factor pathway inhibitor measurement | 1.22e-03 | 7 | 228 | 2 | EFO_0007968 | |
| Disease | endometrial adenocarcinoma (is_implicated_in) | 1.22e-03 | 7 | 228 | 2 | DOID:2870 (is_implicated_in) | |
| Disease | diet measurement | ZMYND11 MC4R DNAH14 PIK3R1 DENND4B RMC1 NIPBL ANAPC4 RAB11FIP2 SMC2 JMJD1C TENM4 SMARCA2 ZNF432 SMARCA4 UNC13C L3MBTL4 SORL1 | 1.41e-03 | 1049 | 228 | 18 | EFO_0008111 |
| Disease | Urologic Neoplasms | 1.61e-03 | 8 | 228 | 2 | C0042076 | |
| Disease | Abdominal Cryptorchidism | 1.61e-03 | 8 | 228 | 2 | C1563730 | |
| Disease | Inguinal Cryptorchidism | 1.61e-03 | 8 | 228 | 2 | C1563731 | |
| Disease | basal cell carcinoma (is_marker_for) | 1.61e-03 | 8 | 228 | 2 | DOID:2513 (is_marker_for) | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 1.61e-03 | 8 | 228 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | Cancer of Urinary Tract | 1.61e-03 | 8 | 228 | 2 | C0751571 | |
| Disease | lung volume | 1.61e-03 | 8 | 228 | 2 | EFO_0600046 | |
| Disease | endometrial cancer (implicated_via_orthology) | 1.61e-03 | 8 | 228 | 2 | DOID:1380 (implicated_via_orthology) | |
| Disease | blindness (implicated_via_orthology) | 1.61e-03 | 8 | 228 | 2 | DOID:1432 (implicated_via_orthology) | |
| Disease | fat body mass, lean body mass | 1.61e-03 | 8 | 228 | 2 | EFO_0004995, EFO_0005409 | |
| Disease | Cornelia De Lange Syndrome | 1.61e-03 | 8 | 228 | 2 | C0270972 | |
| Disease | Bilateral Cryptorchidism | 1.61e-03 | 8 | 228 | 2 | C0431663 | |
| Disease | Unilateral Cryptorchidism | 1.61e-03 | 8 | 228 | 2 | C0431664 | |
| Disease | sarcoma (is_implicated_in) | 1.61e-03 | 8 | 228 | 2 | DOID:1115 (is_implicated_in) | |
| Disease | retinal disease (biomarker_via_orthology) | 1.61e-03 | 8 | 228 | 2 | DOID:5679 (biomarker_via_orthology) | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 2.06e-03 | 9 | 228 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | pterygium (is_marker_for) | 2.06e-03 | 9 | 228 | 2 | DOID:0002116 (is_marker_for) | |
| Disease | Carcinoma, Small Cell | 2.06e-03 | 9 | 228 | 2 | C0262584 | |
| Disease | Cryptorchidism | 2.57e-03 | 10 | 228 | 2 | C0010417 | |
| Disease | 3-methyl-2-oxobutyrate measurement | 2.57e-03 | 10 | 228 | 2 | EFO_0021020 | |
| Disease | Fanconi anemia (is_implicated_in) | 2.57e-03 | 10 | 228 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | Burkitt Lymphoma | 2.69e-03 | 36 | 228 | 3 | C0006413 | |
| Disease | coagulation factor XA measurement | 3.12e-03 | 11 | 228 | 2 | EFO_0020266 | |
| Disease | epilepsy, response to xenobiotic stimulus | 3.12e-03 | 11 | 228 | 2 | EFO_0000474, GO_0009410 | |
| Disease | hypertension (implicated_via_orthology) | 3.23e-03 | 128 | 228 | 5 | DOID:10763 (implicated_via_orthology) | |
| Disease | body height at birth | 3.64e-03 | 40 | 228 | 3 | EFO_0006784 | |
| Disease | bronchopulmonary dysplasia (biomarker_via_orthology) | 3.73e-03 | 12 | 228 | 2 | DOID:11650 (biomarker_via_orthology) | |
| Disease | basal cell carcinoma (is_implicated_in) | 3.73e-03 | 12 | 228 | 2 | DOID:2513 (is_implicated_in) | |
| Disease | progression free survival, urinary bladder cancer | 3.73e-03 | 12 | 228 | 2 | EFO_0004920, MONDO_0001187 | |
| Disease | Schizophrenia | LAMA1 CYFIP1 NRXN2 SV2A KCNN3 TACR3 PICK1 VPS39 NTS CASP3 TENM4 WDR11 CSNK1E SMARCA2 TP53 | 3.81e-03 | 883 | 228 | 15 | C0036341 |
| Disease | Malignant neoplasm of breast | MDM2 PTPRD PER3 TIMELESS ANAPC5 NIPBL VEGFC KPNA5 VPS39 CSNK1D CHD5 TENM1 ZNF432 CLUL1 TP53 DOP1A SORL1 | 4.31e-03 | 1074 | 228 | 17 | C0006142 |
| Disease | glycine measurement | 4.32e-03 | 137 | 228 | 5 | EFO_0009767 | |
| Disease | Coffin-Siris syndrome | 4.38e-03 | 13 | 228 | 2 | C0265338 | |
| Disease | coagulation factor X measurement | 4.38e-03 | 13 | 228 | 2 | EFO_0020265 | |
| Disease | glutaroyl carnitine measurement | 4.38e-03 | 13 | 228 | 2 | EFO_0021005 | |
| Disease | 3-carboxy-4-methyl-5-propyl-2-furanpropanoate CMPF measurement | 4.38e-03 | 13 | 228 | 2 | EFO_0021053 | |
| Disease | T-cell surface glycoprotein CD3 epsilon chain measurement | 4.38e-03 | 13 | 228 | 2 | EFO_0802114 | |
| Disease | cancer (implicated_via_orthology) | 5.00e-03 | 268 | 228 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | stomach cancer (is_marker_for) | 5.02e-03 | 142 | 228 | 5 | DOID:10534 (is_marker_for) | |
| Disease | cholesterol to total lipids in large VLDL percentage | 5.09e-03 | 45 | 228 | 3 | EFO_0022236 | |
| Disease | benign prostatic hyperplasia | 5.09e-03 | 14 | 228 | 2 | EFO_0000284 | |
| Disease | Leber hereditary optic neuropathy (is_implicated_in) | 5.09e-03 | 14 | 228 | 2 | DOID:705 (is_implicated_in) | |
| Disease | unipolar depression, anxiety | 5.09e-03 | 14 | 228 | 2 | EFO_0003761, EFO_0005230 | |
| Disease | Sarcoma, Spindle Cell | 5.09e-03 | 14 | 228 | 2 | C0205945 | |
| Disease | Sarcoma, Epithelioid | 5.09e-03 | 14 | 228 | 2 | C0205944 | |
| Disease | Gastrointestinal Stromal Sarcoma | 5.75e-03 | 47 | 228 | 3 | C3179349 | |
| Disease | Proteinuria | 5.84e-03 | 15 | 228 | 2 | HP_0000093 | |
| Disease | African Burkitt's lymphoma | 5.84e-03 | 15 | 228 | 2 | C0343640 | |
| Disease | Alobar Holoprosencephaly | 5.84e-03 | 15 | 228 | 2 | C0431363 | |
| Disease | Burkitt Leukemia | 5.84e-03 | 15 | 228 | 2 | C4721444 | |
| Disease | hemorheological measurement | 5.84e-03 | 15 | 228 | 2 | EFO_0803374 | |
| Disease | gait measurement | 6.31e-03 | 150 | 228 | 5 | EFO_0007680 | |
| Disease | complement factor H-related protein 4 measurement | 6.46e-03 | 49 | 228 | 3 | EFO_0600091 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 6.46e-03 | 49 | 228 | 3 | EFO_0022256 | |
| Disease | dual specificity mitogen-activated protein kinase kinase 2 measurement | 6.64e-03 | 16 | 228 | 2 | EFO_0008112 | |
| Disease | Lobar Holoprosencephaly | 6.64e-03 | 16 | 228 | 2 | C0431362 | |
| Disease | Semilobar Holoprosencephaly | 6.64e-03 | 16 | 228 | 2 | C0751617 | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 6.64e-03 | 16 | 228 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | Gastrointestinal Stromal Tumors | 6.83e-03 | 50 | 228 | 3 | C0238198 | |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 7.38e-03 | 99 | 228 | 4 | DOID:11446 (biomarker_via_orthology) | |
| Disease | Paroxysmal atrial fibrillation | 7.42e-03 | 156 | 228 | 5 | C0235480 | |
| Disease | prostate cancer (is_marker_for) | 7.42e-03 | 156 | 228 | 5 | DOID:10283 (is_marker_for) | |
| Disease | familial atrial fibrillation | 7.42e-03 | 156 | 228 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 7.42e-03 | 156 | 228 | 5 | C2585653 | |
| Disease | Holoprosencephaly | 7.49e-03 | 17 | 228 | 2 | C0079541 | |
| Disease | partial epilepsy | 7.49e-03 | 17 | 228 | 2 | EFO_0004263 | |
| Disease | banks of the superior temporal sulcus volume measurement | 7.49e-03 | 17 | 228 | 2 | EFO_0010286 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HYMRRFAKTISNVLL | 1216 | Q9UPW8 | |
| ILDRHNFAIMTKYIS | 236 | Q9H9S4 | |
| SREQLIDYLMLKVAH | 1286 | Q96RT1 | |
| AIMIVTYFLTIHALQ | 231 | P41595 | |
| LYKHRMATVLAQLEE | 376 | Q9BWT7 | |
| FHDTEYVRMLLLTKN | 211 | Q5JVX7 | |
| MARKFTHISALLQYI | 251 | Q9UJX5 | |
| VKELQLELYHTVMYR | 526 | Q8TDI0 | |
| LLQKMDSRLYVHTTF | 491 | O60477 | |
| RYIVHMRVNKLLFAA | 71 | O43506 | |
| NHILTLMSVAARIYK | 241 | Q9UP79 | |
| EAIHMYIALVKVFNT | 951 | Q86SQ4 | |
| EMLIFAALQYHISKL | 311 | Q9BQL6 | |
| QKYRQIFSVMVRHEL | 211 | Q8IYW2 | |
| RKSVQVAYDRAMIHL | 1176 | Q9ULD4 | |
| VMLNHLYALSIKDSV | 236 | O43741 | |
| LLLDRHNFTIMTKYI | 236 | Q9Y376 | |
| TYVLAHLNRKLSMED | 201 | Q5JWR5 | |
| HYVTIIIMTKINRCV | 386 | A1A5B4 | |
| VIARYKTLVSMRHDL | 171 | Q96M95 | |
| YHELVLTTKEFMRQV | 986 | O60231 | |
| YADKLEFMHILTRVN | 226 | P42574 | |
| IKHSLFQDYLLMDTV | 491 | Q96F81 | |
| IIQTHFRAYIFAMKV | 1611 | Q8IZT6 | |
| MQARKMYIHILTSVI | 1646 | Q8IZT6 | |
| MYIHILTSVIKIQSY | 1651 | Q8IZT6 | |
| YHTMRKAAIVIQVRC | 2136 | Q8IZT6 | |
| IEHYILSVMNIVAKL | 271 | Q9UKP5 | |
| NVINEIMSTERHYIK | 106 | O43307 | |
| RLVELLMHNDYKVVS | 301 | O15131 | |
| VFKERIGYTHMLEVL | 396 | Q6ZS30 | |
| VIIHTIQKGQYMRTL | 2516 | Q6ZS30 | |
| RNSYLATLTEKMVHI | 756 | Q6PCD5 | |
| IYHLQSKVPTFVRML | 61 | Q00169 | |
| QLADMVSSERHKLYL | 876 | P57740 | |
| HLYYNVTEKVRRIME | 536 | Q32P28 | |
| FASILQSIMYRHQKR | 596 | Q96PH1 | |
| IEASHMVYGQKARLL | 556 | Q7Z304 | |
| LNYFFRAIQELMKIH | 366 | Q969Q6 | |
| VVGLFLRHMILAYSK | 131 | Q9UJX4 | |
| MHAYTVQRLYKAILG | 451 | O43747 | |
| TMLYICERHFQKVLN | 1466 | Q9NRD9 | |
| LGRYMVHLSFEEITK | 261 | Q7RTW8 | |
| MQIELARYIKTSAHY | 311 | Q7L576 | |
| HRSYVSTMILEVVKN | 356 | Q9NVI1 | |
| NFGLMTYRKAIHTVV | 271 | Q96PD6 | |
| VLYMLKNVRVLGHFE | 186 | Q8IY17 | |
| MVKHRAYEQALNLYT | 266 | Q96EY7 | |
| VVSSQRLHKPMYIFL | 51 | Q9GZK7 | |
| EIIIKMHGSQLTQRY | 136 | Q6ZMT4 | |
| ITRLHKAMVFLEYFT | 381 | Q8WVX9 | |
| YMVHLLELAVTFIER | 131 | Q9NVX0 | |
| HAKRKTVTAMAVVYV | 76 | Q99525 | |
| ATVHIRMAFLRKVYS | 26 | Q9HC24 | |
| SHSSKLYIVIMVTII | 221 | P04201 | |
| TMAYIQDAKHRLTLL | 921 | Q16706 | |
| LKVIYHTATMLQVKI | 996 | Q2M2H8 | |
| MLTNGTFEYIRHKVL | 256 | Q09327 | |
| SIMYLVLVLAVQVHA | 146 | Q8N5M9 | |
| RYLTMLQLIQFHVTI | 216 | Q9GZR5 | |
| ICKRRVHMYDTVSQI | 541 | Q86Z02 | |
| YATTVQVKEVNRMHI | 176 | P53671 | |
| IQLLSRMEYVHSKNL | 146 | Q9HCP0 | |
| QVKNILYHAVKEMVR | 2511 | Q15652 | |
| LVVLYHAREIQLFMV | 156 | Q92952 | |
| RAQAMIYKLVVHGLL | 2591 | Q15751 | |
| AIQLITRMEYVHTKS | 146 | P78368 | |
| IVRTVFHKLYSAAMT | 1846 | Q5CZC0 | |
| YIHQMISVKNFILAA | 1211 | Q10570 | |
| FIVLKMVNYRLHRAL | 71 | Q96RV3 | |
| FTIIKLVSYRLHLMF | 71 | A6NKB5 | |
| RSLMVAIHQKVLKYA | 316 | P56645 | |
| FATIKTVNYRLHAMF | 71 | Q9H6A9 | |
| HQYLYAMTEKQVTRV | 496 | Q9UIW2 | |
| MHYNVRDGATLILSK | 1546 | O15031 | |
| YLIARVMLLHSKLFT | 416 | Q9UGI6 | |
| YSVKTQQIHTRMLRL | 301 | Q9H2C8 | |
| MLITVSYIHILQAVF | 231 | Q8NGF0 | |
| IYSMHIFLTERKLTV | 911 | Q86W56 | |
| QMISRIEYIHSKNFI | 111 | P48730 | |
| STHKQRVIVMLYNKV | 1376 | Q6KC79 | |
| AMVNKLHYLVTISVD | 391 | Q9P2S2 | |
| RSVTVTVAYLMQKLH | 296 | Q99956 | |
| QTHKTRMNLVIFRYV | 2221 | Q6ZR08 | |
| VFMRETHLNERAKYV | 536 | Q8IY47 | |
| LQKLVLSHMDVSRYV | 236 | P0DUQ1 | |
| KIYNSILMFRHSQEL | 596 | Q8NA19 | |
| QVDKMASLYNIHLRT | 406 | Q96EN8 | |
| TIIAYIMKSCHQRQL | 151 | Q9HB14 | |
| VLVFIFVLLMRYKVH | 551 | Q9BTN0 | |
| MAAYKLVLIRHGEST | 1 | Q8N0Y7 | |
| LADQMISRIEYVHTK | 116 | Q8N752 | |
| AIYKQSQHMTEVVRR | 161 | P04637 | |
| YVVTELMQSDLHKII | 216 | Q9UBE8 | |
| MIDVHVLADAFKRYL | 176 | P27986 | |
| LIKNHYMARIVELTS | 666 | Q6ZMI0 | |
| MQIELARYIKTSAHY | 311 | Q96F07 | |
| YLMHAKQQLVTTAKR | 391 | P42694 | |
| LISRMEYVHSKNLIY | 146 | Q9Y6M4 | |
| VLYMLKNVRVLGHFE | 136 | Q6ZV29 | |
| LRVVTIQSAKLGHYM | 111 | Q92914 | |
| FSLEAMLTIYQLHKI | 96 | P30990 | |
| LKKYHLMQFAEVTRA | 271 | Q5JVF3 | |
| TLHDMRYQKLIVQIL | 446 | P52757 | |
| RVKEILIFMICVAYH | 851 | Q9Y2I7 | |
| DGMKLVQTRSILHYI | 61 | O15217 | |
| TMFKQTKAYERHVLL | 301 | Q96IV6 | |
| HEYVLAVRMTSIQCK | 1831 | P46100 | |
| FVLRMKEAYTHAQIS | 846 | Q13535 | |
| IRKLQLLAHQYMISS | 56 | O60308 | |
| MKFSVSALEHRVYEV | 611 | O60308 | |
| VVSMLLRLIQYHQVL | 1571 | P42858 | |
| FLHIMKTISYETLIA | 1341 | Q96BY6 | |
| VEQHTLAKYLMELTL | 281 | O95067 | |
| RAVKYSMSHIAQIPV | 681 | A6NNT2 | |
| KNLMLNYIVVCITHF | 591 | Q9H799 | |
| KDAIMVERLIHAIYN | 141 | Q9P109 | |
| LAYIITIHKELAMFV | 111 | Q6ZNI0 | |
| NMLYLAKVHQDTYIR | 376 | Q96JJ3 | |
| MSDYHIQIKNISRAI | 511 | Q5T0N1 | |
| LALINRKYDEVLHMV | 601 | P53621 | |
| RYSDIVVHRLLMAAI | 801 | Q8TF46 | |
| MRKTLGHNLLVSELY | 706 | Q13619 | |
| RQMAIHKRFFTSLVL | 711 | O75417 | |
| HMATNYKLEFTALVV | 41 | Q96SY0 | |
| FNILKAYIEVMAHSV | 146 | Q8N118 | |
| IRYSALMELLTTHQK | 1956 | Q8WXX0 | |
| VYGLFMLHTKIVNRK | 326 | Q6K0P9 | |
| LIRAQVVYYSEMHKI | 201 | Q9NQY0 | |
| VYSVAMTIQHIVAEK | 716 | Q9BZC7 | |
| YTIKVHMNLLLAVFL | 441 | Q9Y653 | |
| MHIISVLEKEIYSIF | 971 | Q0VDD8 | |
| IQHIRGMYKVDLSAS | 2906 | Q99698 | |
| VINDYHFRMVKSLLS | 16 | Q16666 | |
| LTSMLIQRVHYAIKK | 306 | P49641 | |
| RYHSIMTVRKALTLI | 151 | P41968 | |
| QYHNIMTVKRVGIII | 156 | P32245 | |
| FAHLLILRDTKTYML | 116 | P02763 | |
| AYHVLRQMESGKVVL | 796 | O75064 | |
| QEVSLRVHLMEYITK | 186 | Q8NC69 | |
| RVHLMEYITKQGFTI | 191 | Q8NC69 | |
| MKRTHLFIVGIYFLS | 1 | O14958 | |
| IQMFKIVLEYLDHRL | 526 | Q8NCS7 | |
| KRASMVHSLIEAYAL | 36 | Q9BY41 | |
| VHSLIEAYALHKQMR | 41 | Q9BY41 | |
| VYVRQEKTLVMNKHV | 431 | P48637 | |
| ILMKVHSRFIVSLAY | 241 | Q15835 | |
| HRLIIFTQSVKSMYL | 1681 | Q9NZJ4 | |
| TFMRHVIVKAYLQVL | 1911 | Q9NZJ4 | |
| ILKALHYMVQTSTFR | 3361 | Q9NZJ4 | |
| HYMVQTSTFRAEKLV | 3366 | Q9NZJ4 | |
| YTVFMFVIVLSSLKH | 161 | Q9HBR0 | |
| LSSQMHESIREYLVK | 176 | Q68D86 | |
| QKLVLSHMDVSRYVS | 141 | H0Y7S4 | |
| DHNRSFIAEMTIYIK | 206 | Q08211 | |
| YQMVFHQATRDVIIK | 616 | Q92845 | |
| NSVAMHKLITLIYSV | 266 | Q8NGC8 | |
| EKTVDIYGHVTLMRA | 1576 | P23468 | |
| ILRHTKMKTATNIYI | 76 | P41146 | |
| HDDYLVMLKAIRILV | 146 | Q9Y224 | |
| LEKLTAIAQHRMTTY | 696 | Q92750 | |
| VHNIVIFMRTSVKIS | 211 | Q9BVX2 | |
| IHLRLGLMFKVNTDY | 166 | O14607 | |
| QLRDKYMFATKVVHL | 301 | Q92673 | |
| MEALTRLHITVSKAY | 151 | Q9HB90 | |
| SLQAAAVLHAIYKEM | 1266 | Q96KN7 | |
| LHVAAAKGYIEVMRL | 231 | Q9BZL4 | |
| TIQTIALITYLMEHK | 756 | P51531 | |
| ILYRHMQAKGILLTD | 976 | P51531 | |
| HLAYGSVITVKNLRM | 336 | Q9UKY4 | |
| KIIHMRDIYSTVIDI | 156 | Q86VY9 | |
| MNHTKALERVSYALL | 216 | Q9UBV2 | |
| LYEELKTRISQFNMH | 706 | Q8NDG6 | |
| SKHIIQYFATIAAMI | 206 | Q9Y2K3 | |
| ILISIAIVRYHMIKH | 131 | Q15761 | |
| RAVLMKIDAFHYIQL | 156 | Q86UY8 | |
| LKMEYAEVRVLHLAH | 436 | Q92696 | |
| VTHLLIRANYNSAKM | 666 | P25391 | |
| LADQMISRIEYVHTK | 116 | P48729 | |
| IILAHKRMRTVTNYF | 56 | P25103 | |
| RSHVYAIIMTDLFTK | 156 | Q9NXP7 | |
| HRKIYTMIYRNLVVV | 96 | Q00987 | |
| LQKLVLSHMDVSRYV | 236 | A6NGN4 | |
| DLHRSFSNVKYVMLE | 821 | Q13635 | |
| IYEYHRVELQMSKIT | 301 | Q6UX71 | |
| MTARRNYDHSLVKVL | 306 | Q05823 | |
| IQDIVVHYTFNKVLM | 421 | P04843 | |
| TIQTIALITYLMEHK | 786 | P51532 | |
| VLYRHMQAKGVLLTD | 1006 | P51532 | |
| QMHPTVVISAYRKAL | 116 | P49368 | |
| YLEKSVMLLLHSQRR | 1886 | Q9UKZ4 | |
| LQKLVLSHMDVSRYV | 236 | A3QJZ7 | |
| KIVHYRQMFLSTELQ | 321 | Q96QE5 | |
| VAEYAIALAQKHMTR | 341 | Q15477 | |
| LAHKRMRTVTNYFLV | 111 | P29371 | |
| LVLYVDSMVKNLHSV | 486 | O60518 | |
| RYQDHTFLKMLLTAV | 1441 | O60287 | |
| VNEFLYVLIVLMKHL | 1916 | O60287 | |
| MIRHLQAVDYASRTK | 471 | Q7L0J3 | |
| AFLAVSVKLLEYMAH | 111 | Q5TBC7 | |
| TIQLHREIVLMSKYS | 331 | Q86X52 | |
| THRVMEYIQQLKDFT | 446 | Q8NHS4 | |
| LTRYNHMLSATVKII | 231 | Q15021 | |
| LQMTRKHLEDTAYLV | 361 | Q15846 | |
| MDRVLLHVDVNYLKS | 201 | Q8WZ69 | |
| MRILYDLHSEVQTLK | 41 | Q8IX90 | |
| LQKLILSHMDVSRYV | 236 | O60810 | |
| MHLALKAYQELLATV | 436 | Q9UNS1 | |
| AVLMHRERYTQAKEI | 326 | Q6DKK2 | |
| CMSKLDVYRQVHSII | 211 | P49767 | |
| LTQNVITYMRTKHFV | 126 | Q8TC21 | |
| VKAVIACILYRAMAH | 636 | Q9BX84 | |
| AIMEVVLATIKQYFH | 1976 | Q8NB66 | |
| VEFMHYIIAARALRK | 166 | O00541 | |
| KEKVLQLTMFQHRYS | 1156 | Q13129 | |
| KMRSVYAHFPINVVI | 91 | P32969 | |
| HKFVIAVLMEYIRSL | 476 | Q96DM3 | |
| SKFVCIYHVREQILM | 626 | Q15269 | |
| IYHVREQILMKRFEI | 631 | Q15269 | |
| HVFVLLLMQRYSKRV | 276 | Q8TCJ2 | |
| MVLVYFQRAHLKLSE | 91 | Q5MJ68 | |
| TAAHIIRLMLKYQKI | 561 | Q9P2N2 | |
| RSAVLVVAYLMIFHN | 231 | Q5VZP5 | |
| LQKLVLSHMDVSRYV | 236 | P0DUQ2 | |
| HIDQTALAVYIAMKT | 1086 | P29144 | |
| DTKLHMALYVLQALT | 166 | Q8NCL8 | |
| FDIAHYLVSVMAVKR | 21 | Q9NVV0 | |
| HNLMFLYTIFIVATK | 206 | Q9NVV0 | |
| LQKLVLSHMDVSRYV | 236 | O60813 | |
| VQLVRHKASQKVYAM | 106 | O75116 | |
| KSMVLLLHSQRQYIF | 1931 | Q6N022 | |
| EKSMVLLLHSQRQYI | 1866 | Q9P273 | |
| ILLHYKFNNRTSVML | 406 | P54274 | |
| SPEKYILFLIVMHRS | 76 | Q7L804 | |
| QKVMREIEHLSRLYI | 221 | O95347 | |
| QTRLLSMAKPVYHAI | 1536 | O75643 | |
| MEQLHRYTKLSYRVV | 261 | P62068 | |
| IANIDRITKYMSRVH | 31 | Q15326 | |
| YFLLVRIKIQHMELQ | 196 | O75436 | |
| TMKRYLIVHQQIHTE | 551 | O94892 | |
| MSSIKHLVYAVIRFL | 1 | Q96EQ0 | |
| ILNMFKVERVHYSST | 236 | Q9NY57 | |
| VLYVFLHAILIMVQA | 246 | Q6NXT6 | |
| AFRHLIEFTYTAKLM | 81 | P52739 | |
| IEMIKVSHLKQYLAV | 571 | Q9BZH6 | |
| DMREILINTLHKYGI | 1011 | A3KMH1 | |
| LHYSVRLVENVIMVL | 351 | Q6PP77 | |
| MTEHTKNLLRAFYEL | 166 | Q9NRD5 | |
| HFLEMRLSKDVTYSV | 846 | Q6ZQQ6 | |
| SAYLQHVQIRLMKDS | 681 | Q6EMB2 | |
| LFIYVHILKDTRMAE | 706 | Q96JC1 | |
| IYKHLMITAQRFTVQ | 3926 | Q5THJ4 | |
| QMISRIEYIHSKNFI | 111 | P49674 | |
| IVIYHMRRKNEDYSI | 826 | O94898 | |
| MYLNEATLLHNIKVR | 66 | Q9UM54 |